What`s inside

Transcription

What`s inside
Final
12th-14th January, 2012 - Singapore
What's inside...
. The Course programme
. Exhibition plan
. General information
. Exclusive interviews
Board of Directors, Scientific Committee Members & Plan
Course Directors
Tian-Hai
Koh
Eric
Eeckhout
Singapore
Switzerland
Programme
Committee Members
Takashi
Akasaka
Jun-Jack
Cheng
Japan
Taiwan
Do Quang
Huan
Myeong-Ki
Hong
Vietnam
South Korea
Rosli
Mohd Ali
Sunarya
Soerianata
Malaysia
Indonesia
Course Co-Directors
Terrance
Chua
Jean
Fajadet
Singapore
France
Junbo
Ge
Soo-Teik
Lim
China
Singapore
Marie-Claude
Morice
Christoph
Naber
France
Germany
Shigeru
Saito
Patrick W.
Serruys
Japan
Netherlands
Aaron
Wong
Singapore
Chairman of PCR
Jean
Marco
Bien Soo
Tan
France
Singapore
Plan
Interactive
Case Corner
Room 2
Room 3
Room
206
Room
205
Room
207
Room
204
Training Village
Exhibition
Hall
Exhibition
Hall
Room 208
Room 203
Room 209
Main Arena
Preview
Room
Room 201
Posters Gallery
Main Entrance
Entrance
ZONE 1
ZONE 2
DAY PASS AND FULL PASS
ACCESS ONLY
ALL TYPES OF BADGES
1 Final Programme / 12th-14th January, 2012 / Singapore
Editorials
Dear Friends,
It gives us great pleasure to welcome all of you to AsiaPCR/SingLIVE 2012.
AsiaPCR/SingLIVE is created with the fundamental building blocks:
patient-centred, innovative session formats, open-mindedness, interactivity, continuous evaluation and improvement. Through the
exchange of views and experience among healthcare professionals, we hope to contribute to the advancement of cardiovascular
care, particularly in Asia.
The 2011 edition saw more than 1,700 attendees from 56 countries, an 11% increase on 2010. Building upon the success of 2011, we
have weaved more case discussions into the programme, with live
demonstrations, adequate time for discussion and an even higher
level of interactivity.
For the 3rd AsiaPCR/SingLIVE, we have lined up core topics on
coronary, structural heart, endovascular/peripheral, imaging as
well as a nurse,technician & radiographer forum.
The structural heart segment will showcase recent developments
in the exciting and emerging field of disease therapies. Experts in
the field will review state-of-the-art treatment for aortic stenosis,
transseptal puncture, mitral regurgitation, left atrial appendage
closure and ASD/PFO, amongst other exciting topics. The advent
of these new minimally invasive techniques allow the modern
Tian-Hai Koh
AsiaPCR/SingLIVE Course Director
National Heart Centre Singapore,
Singapore
PCR Family is an organisation dedicated to education and information in the field of cardiovascular therapies, most notably for cardiovascular intervention and interventional medicine. Our motto is
“innovation in education at work”
Our aim is to help the community to respond to the fundamental
question that impacts the daily practice of every cardiologist:
“What is the best management and technical strategy for each patient presenting with a specific cardiac disease, given his clinical situation, in the light of local experience and best available evidence?”
PCR Family is not to be considered as a model. None of the numerous educational practices can constitute a strict model since each
country and region have their own particularities.
Education in PCR activities is based on sharing knowledge and experience. Our courses are made “by and for” local participants as
well as those from abroad. We would like you to consider yourself
as simultaneously the source, the inspiration and the target of the
educational content.
interventionalist to offer a wide range of therapeutic modalities
that were mainly unheard of just a decade ago.
A new area of focus will be on hypertension management using
radiofrequency renal denervation. This is an exciting treatment
option that will expand the repertoire of the cardiovascular interventionalist.
We have incorporated the nurses and technician forum into this
year’s programme. This permits our nursing and paramedical colleagues to learn the technical aspects of device preparation, anticipate technical issues and manage complications.
Live transmissions remain an integral element of the course with
Asian satellite transmission sites from China, India, Indonesia and
Singapore.
AsiaPCR/SingLIVE 2012 presents an excellent opportunity for a
meeting of minds, making new acquaintances and renewing old
ties. Do also make time to visit our dynamic city with a harmonious blend of culture, cuisine, arts and architecture - a uniquely
Singapore experience.
Welcome once again and we hope you will have an enjoyable time
and an enriching learning experience here at AsiaPCR/SingLIVE.
Eric Eeckhout
AsiaPCR/SingLIVE Course Director
Centre Hospitalier Vaudois,
Lausanne, Switzerland
If the cardiovascular community of Asia-Pacific region wishes to
benefit from the knowledge and experience of PCR Family in education, it will be an honor for us. Our will is to share: together we
can achieve more and build a new model of education that will
benefit everyone, worldwide.
During AsiaPCR/SingLIVE, we would like you to become active participants: express your concerns and issues, which are also experienced by many others. This will bring a major benefit to the whole
cardiovascular community. We strive to deliver information with a
balanced and constructive spirit, free from any external influence.
Thank you for participating in AsiaPCR/SingLIVE.
Prof. Jean Marco
Chairman of PCR
Final Programme / 12th-14th January, 2012 / Singapore
2
Live demonstrations programme
See Live demonstrations from 5 centres
National Heart Centre
Medanta Medicity
Singapore
Gurgaon, India
Thursday 12th
Main Arena
PCI in patients with complex left main disease in 2012 and beyond
08:40-09:30: Jean Fajadet - France
Soo Teik Lim - Singapore
Complex PCI in patients with difficult subsets in 2012 and beyond
14:30-15:15: Kay Woon Ho - Singapore
Aaron Wong- Singapore
Takashi Akasaka - Japan
Friday 13th
Main Arena
Left main trunk and bifurcation - basics to practices
Lunch symposium with an unrestricted educational grant from Terumo
12:40-13:25: Satoru Sumitsuji - Japan
PCI in patients with complex bifurcation lesion in 2012 and beyond
15:55-16:40: Stanley Chia - Singapore
Tian Hai Koh - Singapore
Saturday 14th
Thursday 12th
Main Arena
PCI in patients with complex left main disease in 2012 and beyond
11:05-11:50: Praveen Chandra - India
Complex PCI in patients with difficult subsets in 2012 and beyond
16:20-17:05: Praveen Chandra - India
Apollo Hospitals
Hyderabad, India
Thursday 12th
Room 2
Drug-eluting balloons - a viable alternative in PCI
Dinner symposium with an unrestricted educational grant from Eurocor
18:25-19:00: J. Shivkumar - India
Main Arena
Non-coronary transcatheter interventions in 2012
▸ on TAVI
08:35-09:20: Paul Chiam - Singapore
Eberhard Grube - Germany
Chung-Yin Lee - Singapore
Shanghai Institute
of Cardiovascular Diseases
Shanghai, China
▸ on renal denervation
10:20-11:05: Chee Tang Chin - Singapore
Sharad Shetty - Australia
Friday 13th
▸ on ASD
11:50-12:20: Eric Eeckhout - Switzerland
Ju Le Tan - Singapore
Saturday 14th
Main Arena
PCI in patients with high-risk acute coronary syndrome in 2012 and
beyond
08:35-09:20 & 10:25-11:10: Jun Bo Ge - China
Room 2
Coronary chronic total occlusion
08:30-09:20: Etsuo Tsuchikane - Japan
Khung Keong Yeo - Singapore
10:30-11:20: Rohit Khurana - Singapore
Masahiko Ochiai - Japan
Harapan Kita
Jakarta, Indonesia
Friday 13th
Main Arena
PCI in patients with complex bifurcation lesion in 2012 and beyond
14:05-14:50 & 17:10-17:55: Sunarya Soerianata - Indonesia
Jean Fajadet - France
3 Final Programme / 12th-14th January, 2012 / Singapore
Session formats
Session formats
NEW Perspectives on
"Call for" based sessions
This new session format is a mini debate based on short lectures on a
given topic, compiled from doctors practicing in different parts of the
world.
The physicians will consider challenging topics from their own personal
perspective. Speakers from different origins will be requested to reflect
on recent publications and share with the audience how it could be
applied in their daily practice, in their institute, region, country…
Join one of the sessions based on submissions:
- Abstracts
- Clinical cases & complications
To discover educational cases encountered by your peers or explore the
broad range of subjects addressed by the presentations.
How should I treat?
Interactive sessions with experts who will discuss complex cases of high
educational value.
They will provide practical approaches and solutions to problems and
unusual situations encountered during PCI.
Based on a concept from EuroIntervention Journal, a challenging case
is presented to two experts who share their opinions on treatment
and patient management.
LTT (Learning The Techniques)
An innovative and interactive concept combining the pedagogical skills
of experienced practitioners and input from younger practitioners.
These sessions are based on a step-by-step decision making process.
Meet the experts
Symposium
Symposia aim to develop themes and present a clear synthesis of studies
and trials.
These industry supported sessions will allow you to integrate practical
solutions to patient problems through knowledge and judgement.
Final Programme / 12th-14th January, 2012 / Singapore
4
Faculty list - Valid as of 28/12/2011
Our sincere thanks to the Guest Faculty
Their unique points of view are shaped by local cultures and constraints that helped us discover new ways of thinking.
The excellent quality of the sessions was assured by the rich diversity of their backgrounds and the breadth of their expertise.
Last name
AGARWAL
AHMED
AHN
AKASAKA
AL SHAFI MAJUMDER
ANG
ANGIOI
AZEEMUDDIN
BERLAND
BIRKEMEYER
BUCHANAN
BUDDHARI
BUENDIA
BURGMANS
CHAE
CHAN
CHAN
CHAN
CHANDRA
CHANDRA
CHAO
CHEAH
CHEN
CHEN
CHEN
CHENG
CHEVALIER
CHIA
CHIAM
CHIN
CHNG
CHONG
CHOO
CHOPRA
CHOU
CHUA
CHUA
CHUA
CHUA
COLOMBO
CUISSET
DESAI
DEVLIN
DHAKAM
DING
DO
DO
DUCROCQ
DUDEK
EECKHOUT
ERGLIS
ESCANED
EWE
FAJADET
FUNG
GAMBHIR
GAO
First name
Country
Praveer
Tamzeed
Taehoon
Takashi
Abdullah
Cheng-Ho, Patrick
Michael
Muhammad
Jacques
Ralf
Gill Louise
Wacin
Siro
Mark
In-Ho
Kam-Tim
Choong Meng
Charles
Subash
Praveen
Tar Toong, Victor
Foong-Koon
Shao-Liang
Ji-Lin
Matt
Jun-Jack
Bernard
Stanley
Paul
Chee Tang
Siew-Ping
Yoon Sin
Maurice
Arun
Chia-Yu
Yeow-Leng
Siang-Jin, Terrance
Gim Chuah
Benjamin
Antonio
Thomas
Devang
Gerard
Sajid
Zee-Pin
Quang Huan
Dai-Do
Gregory
Dariusz
Eric
Andrejs
Javier
See-Hooi
Jean
Chi-Yan Raymond
Daljeet S.
Runlin
INDIA
BANGLADESH
SOUTH KOREA
JAPAN
BANGLADESH
BRUNEI DARUSSALAM
FRANCE
PAKISTAN
FRANCE
GERMANY
ITALY
THAILAND
SPAIN
SINGAPORE
SOUTH KOREA
HONG KONG
SINGAPORE
SINGAPORE
INDIA
INDIA
SINGAPORE
SINGAPORE
CHINA
CHINA
TAIWAN
TAIWAN
FRANCE
SINGAPORE
SINGAPORE
SINGAPORE
SINGAPORE
MALAYSIA
SINGAPORE
INDIA
TAIWAN
SINGAPORE
SINGAPORE
SINGAPORE
SINGAPORE
ITALY
FRANCE
INDIA
NEW ZEALAND
PAKISTAN
SINGAPORE
VIETNAM
SWITZERLAND
FRANCE
POLAND
SWITZERLAND
LATVIA
SPAIN
SINGAPORE
FRANCE
HONG KONG
INDIA
CHINA
5 Final Programme / 12th-14th January, 2012 / Singapore
Last name
GARCIA DEL BLANCO
GARG
GE
GHANI
GNANARAJ
GOGNA
GOH
GOH
GOTABHAYA
GRUBE
GUNASEGARAN
GUO
GWON
HAN
HANIF
HIREMATH
HO
HO
HSIEH
INOUE
IRANI
JAFARY
JANG
KAPOOR
KAR
KARJALAINEN
KAUL
KENG
KHAN
KHURANA
KLEBER
KOH
KONGPHANICH
KOYAMA
KRUCOFF
KUM
KWOK
KWOK
KYAW
KYAW
LAM
LAM
LAM
LAU
LEE
LEE
LEE
LEE
LI
LIM
LIM
LIM
LIU
LO
LOW
LOW
LOW
First name
Country
Bruno
Scot
Jun Bo
Rohaizah Binti Abdul
Anand
Apoorva
Yu-Tang, Peter
Ping-Ping
Ranasinghe
Eberhard
Kurugulasigamoney
Wen-Yi
Hyeon-Cheol
Ya-Ling
Bashir
Shirish M. S.
Kheng Thye
Kay-Woon
I-Chang
Naoto
Farah
Fahim H.
Yang-Soo
Rajneesh
Saibal
Pasi
Upendra
Yung-Jih, Felix
Amol
Rohit
Franz
Tian-Hai
Chutcharn
Yutaka
Mitchell W.
Steven
Veronica
Robert
Soe-Win
Zaya
Kai-Huat
Leslie
Yat Yin
Te-Neng
Michael Kang-Yin
Chung-Yin
Stephen W. L.
Ronald Chi-Hang
Steven Siu-Lung
Soo Teik
Yean-Teng
Michael
Eugene
Tsz-Ho, Sidney
Adrian
Reginald I.
Shoen Choon Seng
SPAIN
UNITED KINGDOM
CHINA
MALAYSIA
INDIA
SINGAPORE
SINGAPORE
SINGAPORE
SRI LANKA
GERMANY
SINGAPORE
CHINA
SOUTH KOREA
CHINA
PAKISTAN
INDIA
SINGAPORE
SINGAPORE
TAIWAN
JAPAN
SINGAPORE
SINGAPORE
SOUTH KOREA
INDIA
UNITED STATES
FINLAND
INDIA
SINGAPORE
INDIA
SINGAPORE
GERMANY
SINGAPORE
THAILAND
JAPAN
UNITED STATES
SINGAPORE
SINGAPORE
SINGAPORE
MYANMAR
MYANMAR
MALAYSIA
SINGAPORE
HONG KONG
SINGAPORE
HONG KONG
SINGAPORE
HONG KONG
SINGAPORE
HONG KONG
SINGAPORE
SINGAPORE
SINGAPORE
SINGAPORE
AUSTRALIA
SINGAPORE
UNITED STATES
SINGAPORE
Faculty list - Valid as of 28/12/2011
Last name
LUKITO
MALIK
MANOHARAN
MARCO
MASKON
MATSUBARA
MAURI
MEHTA
MEHTA
MEREDITH
MITHRAKUMAR
MOHD ALI
MOMENUZZAMAN
MORICE
MULLER
MUNAWAR
MURAMATSU
MUTHUSAMY
NABER
NAKAMURA
NAKAMURA
NAKAZAWA
NG
NG
NG
NGUYEN
NGUYEN
NGUYEN
OCHIAI
OIKAWA
ONG
ONG
ONG
ONG
PATEL
PATHAN
PHAM
PIETILÄ
POH
PUA
PUNAMIYA
RADKE
RAHMAN
RAJAN
RIFQI
ROBLESS
ROSLI
ROSMAN
SAKHOV
SANTOSO
SENARATNE
SENEVIRATNE
SENGOTTUVELU
SERRUYS
SETH
SETHI
SHETTY
First name
Country
Antonia Anna
Fazila
Ganesh
Jean
Oteh
Tetsuo
Fina
Ashwin
Haresh
Ian T.
Sinnathuraj
Sheikh Abdul Kader
N. A. M.
Marie-Claude
Olivier
Muhammad
Toshiya
Tamil
Christoph K.
Masato
Sunao
Gaku
Swee-Choon
Richard
Keng Sin
Lan Hieu
Quang-Tuan
Ngoc-Quang
Masahiko
Yuji
Andrew
Paul
Tiong Kiam
Hean-Yee
Tejas Madhusadan
Asad
Manh-Hung
Mikko
Kian-Keong
Uei
Sundeep
Peter
Afzalur
Dheeraj
Sodiqur
Peter
Mohd Ali
Azhari
Orazbek
Teguh
Vajira
Sujith
G.
Patrick W.
Ashok
Rajiv
Sharad
INDONESIA
BANGLADESH
UNITED KINGDOM
FRANCE
MALAYSIA
JAPAN
SPAIN
INDIA
INDIA
AUSTRALIA
SRI LANKA
MALAYSIA
BANGLADESH
FRANCE
SWITZERLAND
INDONESIA
JAPAN
MALAYSIA
GERMANY
JAPAN
JAPAN
JAPAN
MALAYSIA
SINGAPORE
SINGAPORE
VIETNAM
VIETNAM
VIETNAM
JAPAN
JAPAN
AUSTRALIA
SINGAPORE
MALAYSIA
SINGAPORE
INDIA
PAKISTAN
VIETNAM
FINLAND
SINGAPORE
SINGAPORE
SINGAPORE
GERMANY
BANGLADESH
CANADA
INDONESIA
SINGAPORE
MALAYSIA
MALAYSIA
KAZAKHSTAN
INDONESIA
SRI LANKA
AUSTRALIA
INDIA
NETHERLANDS
INDIA
INDIA
AUSTRALIA
Last name
First name
Country
SHIVKUMAR
J.
INDIA
SIDIPRATOMO
Prijo
INDONESIA
SIM
Kui-Hian
MALAYSIA
SIN
Yoong-Kong, Kenny
SINGAPORE
SITANBAOLI
Biegelan
KAZAKHSTAN
SOERIANATA
Sunarya
INDONESIA
SPANGER
Manfred
AUSTRALIA
SRINIVASA
K. H.
INDIA
SRIRAM
Narayanan
SINGAPORE
SUMITSUJI
Satoru
JAPAN
SURYAPRANATA
Harry
NETHERLANDS
TAN
Jack
SINGAPORE
TAN
Ju Le
SINGAPORE
TAN
Huay Cheem
SINGAPORE
TAN
Swee-Yaw
SINGAPORE
TAN
Ru-San
SINGAPORE
TAN
Bien-Soo
SINGAPORE
TANEJA
Manish
SINGAPORE
TANG
Alex
MALAYSIA
TANGCO
Rogelio
PHILIPPINES
TAY
Edgar
SINGAPORE
TAY
Kiang Hiong
SINGAPORE
TEDJOKUSUMO
Pintoko
INDONESIA
TEO
Swee Guan
SINGAPORE
TEO
Wee-Siong
SINGAPORE
THACHATHODIYL
Rajesh
INDIA
THOMAS
Martyn
UNITED KINGDOM
TING
Peter
SINGAPORE
TRESUKOSOL
Damras
THAILAND
TRISNOHADI
Hanafi
INDONESIA
TSUCHIKANE
Etsuo
JAPAN
UDAYACHALERM
Wasan
THAILAND
UDDIN
Mir Jamal
BANGLADESH
VARENNE
Olivier
FRANCE
VERHEYE
Stefan
BELGIUM
WALTERS
Darren
AUSTRALIA
WAN AZMAN
Wan Ahmad
MALAYSIA
WESSELY
Rainer
GERMANY
WONG
Aaron
SINGAPORE
WONG
Philip
SINGAPORE
WONG
Daniel
SINGAPORE
WONGPRAPARUT
Nattawut
THAILAND
WU
Chiung-Jen
TAIWAN
YAHYA
Achmad Fauzy
INDONESIA
YAMASHITA
Takehiro
JAPAN
YAMIN
Muhammad
INDONESIA
YAN
Peter
SINGAPORE
YEO
Khung Keong
SINGAPORE
YEOW
Tow-Non
SINGAPORE
YIP
James
SINGAPORE
YONG
Quek-Wei
SINGAPORE
YOSHIMACHI
Fuminobu
JAPAN
YUNIADI
Yoga
INDONESIA
ZAMBAHARI
Robaayah
MALAYSIA
ZHANG
Bin
CHINA
Final Programme / 12th-14th January, 2012 / Singapore
6
Posters Gallery
Visit the Posters Gallery
We would like to thank all those who submitted an abstract this year. From the 89 submissions, we are pleased to list the abstracts
selected for display in the Posters Gallery. Make sure you reserve some time to browse the Gallery.
Visit the Posters Gallery and participate in the moderated discussions:
> Thursday 12th: 16:30 - 17:30 with Eric Eeckhout and Aaron Wong
> Friday 13th: 9:00 - 10:00 with Wan Ahmad Wan Azman and Philip Wong
> Friday 13th: 15:00 - 16:00 with Fina Mauri and Andrew Ong
ID01
ID11
SHETA M.K., Al-Azhar university, CAIRO, EGYPT
LI X., LI T., FU N., HU Y., CONG H.
Tianjin Chest Hospital, TIANJIN, CHINA
Correlation between cTCD and cTEE for detection of right to left shunt in patients
with cerebrovascular stroke
ID02
A randomised comparison of Sirolimus-eluting stent implantation with
Zotaromlimus-eluting stent implantation for the treatment of total coronary
occlusions: one-year clinical and eight-month angiographic outcome of the
PRISON III trial
A meta-analysis about Angiotensin-converting enzyme Inhibitor' effect on
contrast-induced nephropathy
ID12
Atorvastatin combining with probucol can reduce serum uric acid level during
perioperative period of intervention
SUTTORP M.J., St Antonius Hospital, NIEUWEGEIN, NETHERLANDS
LI X., WANG Y., LI Z., ZHANG Y., XIAO J., ZHAO R., CONG H.
Tianjin Chest Hospital, TIANJIN, CHINA
ID03
ID13
Radial artery patency post percutaneous coronary intervention with intravenous
Enoxaparin as procedural anticoagulant
WONG C.P., HO H.H., TAN J., LOH J.K., OOI Y.W., JAFARY F.H., FOO D., ONG P.J.
Tan Tock Seng Hospital, SINGAPORE, SINGAPORE
ID04
Long-term outcomes of percutaneous therapy for true bifurcation lesions treated
with drug-eluting stents using the 'Shunt' technique
Evaluation of SYNTAX score for unprotected left main coronary disease
HORI M., IIJIMA R., NAKAMURA M.
Toho university Ohashi medical center, TOKYO, JAPAN
ID14
Single centre experience and outcome of primary PCI for STEMI without on-site
surgical back-up
SHETTY P.C., Wollongong Hospital, HORSLEY, AUSTRALIA
SHETTY P.C.
Wollongong Hospital, HORSLEY, AUSTRALIA
ID05
ID15
SHETTY P.C., Wollongong Hospital, HORSLEY, AUSTRALIA
ORABY M., NASR G., HAWARY A., SABAH M.
Suez canal medical school, ISMAILIA, EGYPT
ID06
ID16
FRIEDRICH G.(1), BONAROS N.(1), SCHACHNER T.(1), GRIMM M.(1), PACHINGER O.(1),
BONATTI J.(2)
(1) Medical University Innsbruck, INNSBRUCK, AUSTRIA ; (2) University of Maryland,
BALTIMORE, UNITED STATES
LIN G.M.
Hualien-Armed Forces General Hospital, HUALIEN, TAIWAN
Long-term outcome of patients who underwent percutaneous coronary
interventions (PCI) for stable and unstable acute coronary syndromes, including
STEMI, in a regional hospital without on-site surgical back-up
Evaluation of cardiac and cerebrovascular events in robotic coronary bypass
surgery and hybrid revascularisation procedures
Safety and feasibility of transradial versus transfemoral approaches for
diagnostic coronary angiography during early phase of the learning curve
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with
ST-segment elevation myocardial infarction treated with primary angioplasty
ID17
ID07
Road to heart via hand. Trans-radial arterial and upper extremity venous access
for cardiac catheterisation - the safety and feasibility study
Risk factors and risk score for prediction of contrast induced nephropathy in
patients undergoing percutaneous coronary intervention
SURYAWANSHI S.
Wockhardt Hospitals, Nashik, Maharashtra,India, NASHIK, INDIA
FU N., LI X., YANG S., XU J., CHEN Y., CONG H.
Tianjin Chest Hospital, TIANJIN, CHINA
ID18
ID08
Angiographic and procedural outcomes of percutaneous coronary intervention
in patients with chronic coronary artery occlusion after intracoronary adenosine
administration
PETRENKO I.(1), POPOVA M.(2), GORKOV A.(1)
(1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular
Surgery»,, SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University, SURGUT,
RUSSIAN FEDERATION
ID09
Efficacy of hydration with normal saline versus hydration with sodium
bicarbonate in the prevention of CIN
ILKHCHOOYI F., SOHRABI B.
Madani Haert Hospital, TABRIZ, IRAN
ID19
Trans-radial versus trans-femoral intervention for the treatment of coronary
bifurcations: result from the the COBIS (COronary BIfurcation Stenting) registry
CHUNG S., SONG P.S., CHOI S.H.
Samsung Medical Center, Sungkyunkwan University School of Medicine, SEOUL, SOUTH
KOREA
Angiographic and procedural outcomes percutaneous coronary intervention of
patients with diabetes mellitus type 2 and chronic coronary artery occlusion
after intracoronary administration adenosine
ID20
PETRENKO I.(1), POPOVA M.(2), PETRENKO O.(1)
(1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular
Surgery»,, SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University, SURGUT,
RUSSIAN FEDERATION
HUANG H.L.
Tzu-Chi Buddhist General Hospital,Taipei Branch, NEW TAIPEI CITY, TAIWAN
ID10
Optimisation contractile function of left ventricle patients with chronic coronary
artery occlusion after intracoronary administration adenosine
PETRENKO I.(1), POPOVA M.(2)
(1) Institution KHMAO «District cardiologic clinic «Center for Diagnosis and Cardiovascular
Surgery», SURGUT, RUSSIAN FEDERATION ; (2) Surgut State University Surgut, KhantyMansy autonomic okrug-Yugra/ Russain Federation, SURGUT, RUSSIAN FEDERATION
Intensive survelliance followed by assisted intervention sustained long-term
outcomes in patients with critical limb ischemia
ID21
Incorporation of balloon-cushion stenting technique in left main coronary artery
bifurcation intervention
KU P.M.
Chi-Mei Medical Center, TAINAN, TAIWAN
Final Programme / 12th-14th January, 2012 / Singapore
8
Posters Gallery
ID22
Late clinical impact of postprocedural incomplete stent apposition and late
acquired incomplete stent apposition after deployment of Zotarolimus eluting
stent or Everolimus eluting stent
LEE S.R.(1), PARK J.(2), HONG Y.(3), RHEW J.(2), CHAE J.(1)
(1) Chonbuk National University Hospital, JEONJU, KOREA, REPUBLIC OF (SOUTH KOREA)
; (2) Presbyterian Medical Center, JEONJU, KOREA, REPUBLIC OF (SOUTH KOREA) ; (3)
Chonnam National University Hospital, GWANGJU, KOREA, REPUBLIC OF (SOUTH KOREA)
ID23
Pulse pressure predict coronary calcification better than other BP parameters
in Women-WECAC (Women & Coronary Artery Calcium) study
LUKITO A.A.
Siloam hospital Lippo Village, TANGERANG, INDONESIA
ID24
Systolic blood pressure correlates to coronary calcification severity in women
- subanalysis of WECAC (Women Coronary Artery Calcium) study
HENDRAWAN T.(1), LUKITO A.A.(2)
(1) Medical School Pelita Harapan Univercity, KARAWACI, INDONESIA ; (2) Siloam Hospital
Lippo Village, KARAWACI, INDONESIA
ID25
The comparison of lesion characteristics, angiographic and clinical outcome
with Sirolimus-eluting stent, Paclitaxel-eluting stent, Zotarolimus-eluting stent
and Everolimus-eluting stent 12 months after implantation
TAKAMA T.
Saiseikai Yokohama-City Eastern Hospitl, YOKOHAMA-CITY, JAPAN
ID26
Three-year outcomes after the implantation of Sirolimus-eluting stent,
Paclitaxel-eluting stent, and Zotarolimus-eluting stent for coronary artery
disease in real world
TAKAMA T.
Saiseikai Yokohama-City Eastern Hospitl, YOKOHAMA-CITY, JAPAN
ID27
Efficacy of using Dio instead of a guide catheter in transradial coronary
intervention
NAKACHI T., FUKUI K., NAKAGAWA T., OHKUSU Y., MUTO K., KATO S., KUSAKAWA Y., ISHII
N.
Kanagawa Cardiovascular and Respiratory Center, YOKOHAMA, JAPAN
ID28
Impact of severity of diabetes on target lesion revascularisation in 5-year
follow up after percutaneous coronary intervention with sirolimus eluting
stents
OKINO S., FUKUZAWA S., SUGIOKA J., IKEDA A., MAEKAWA J., ICHIKAWA S., KAMIOKA
N., KUROIWA N., OKAMOTO S.
Funabashi Municipal Medical Center, FUNABASHI, JAPAN
ID29
ID32
The DIVERGE trial (drug-eluting stent intervention for treating side branches
effectively): 3-year clinical results
VERHEYE S.(1), DENS J.(2), DUBOIS C.(3), WORTHLEY S.(4), MCCLEAN D.(5),
OTTERVANGER J.P.(6), MEREDITH I.(7), UREN N.(8), WIJNS W.(9), WHITBOURN R.(10),
ORMISTON J.(11)
(1) ZNA Middelheim Hospital, ANTWERP, BELGIUM ; (2) Zieknehuizen Oost Limburg St.
Jan, GENK, BELGIUM ; (3) UZ Gasthuisberg, LEUVEN, BELGIUM ; (4) Royal Adelaide
Hospital, ADELAIDE, AUSTRALIA ; (5) Christchurch Hospital, CHRISTCHURCH, NEW
ZEALAND ; (6) Isala Klinieken, ZWOLLE, NETHERLANDS ; (7) Monash Medical Center,
CLAYTON, AUSTRALIA ; (8) Royal Infirmary, EDINBURGH, UNITED KINGDOM ; (9) OLV
Cardiovascular Center, AALST, BELGIUM ; (10) St. Vincent's Hospital, MELBOURNE,
AUSTRALIA ; (11) Auckland City Hospital, AUCKLAND, NEW ZEALAND
ID33
Fixed, low dose unfractionated Heparin for coronary angioplasty in acute
coronary syndrome patients
AGARWAL S.K., BASLAIB F.O., BINBREK A.S.
Rashid Hospital, DUBAI, UNITED ARAB EMIRATES
ID34
Left main coronary stenting in a non surgical octogenarian population: a
possible approach
DAHDOUH Z.(1), ROULE V.(2), LOGNONÉ T.(2), SABATIER R.(2), GROLLIER G.(2)
(1) CHU de caen, CAEN, FRANCE ; (2) Cardiology, CAEN, FRANCE
ID35
Prediction of future acute coronary syndrome in chest pain unit patients
initially discharged with a negative evaluation
CAMARO C., TEN CATE T., BROUWER M., CRAMER E., DE BOER M.
UMC St Radboud, NIJMEGEN, NETHERLANDS
ID36
Drug eluting balloon in daily clinical practice
TEN CATE T., CAMARO C., HAUTH J., DE BOER M., SURYAPRANATA H.
UMC St Radboud, NIJMEGEN, NETHERLANDS
ID37
Safety and efficacy of early head-up strategy after femoral artery sheath
removal. Single-center randomised controlled study
KANESHIRO N., UTSUNOMIYA M., MASATO N., KAORU S.
Toho University Ohashi Medical Center, TOKYO, JAPAN
ID38
Direct aspiration of a large thrombus in acute myocardial infarction using a
standard 6Fr guide catheter
SHIMADA Y., KINO N., YANO K., TONOMURA D., TAKEHARA K., FURUBAYASHI K.,
KUROTOBI T., TSUCHIDA T., FUKUMOTO H.
Shiroyama Hospital, HABIKINO, JAPAN
ID39
Radiofrequency ablation in adults with tachycardia induced cardiomyopathy
Index of microcirculatory resistance after elective percutaneous coronary
intervention can predicts myocardial damage
GEORGE G., SELVARAJ R., GOBU P., BABU E., SANTHOSH S., BALACHANDER J.
JIPMER, PUDUCHERRY, INDIA
SAIGUSA T.
Shinshu University, MATSUMOTO, JAPAN
ID40
ID30
Impact of acute coronary syndrome on clinical outcomes in patients with
coronary bifurcation lesions treated with drug-eluting stents
Predictor of microcirculatory damage after elective percutaneous coronary
intervention
SONG P.S., CHOI S.H., CHUNG S., SONG Y.B., HAHN J.Y., CHOI J.H., LEE S.H., GWON H.C.
Samsung Medical Center, SEOUL, SOUTH KOREA
SAIGUSA T.
Shinshu University, MATSUMOTO, JAPAN
ID41
ID31
Treatment of diabetic patients treated with a new generation drug-eluting
stent: two-year clinical outcomes
SANTOSO T.(1), DAMRAS T.(2), NAIR D.(3), WILKINS G.(4), SUNARYA S.(5), WALTERS
D.(6), JAYASINGHE R.(7), WAN AHMAD W.A.(8), SIM K.H.(9), ONG T.K.(9), LOW A.(10),
GHAPAR A.K.(11), KOH T.H.(12)
(1) Medistra Hospital, JAKARTA, INDONESIA ; (2) Siriraj Hospital, BANGKOK, THAILAND ;
(3) Tan Tock Seng Hospital, SINGAPORE, SINGAPORE ; (4) Dunedin Hospital, DUNEDIN,
NEW ZEALAND ; (5) Harapan Kita Hospital, JAKARTA, INDONESIA ; (6) The Prince Charles
Hospital, BRISBANE, AUSTRALIA ; (7) Gold Coast Hospital, QUEENSLAND, AUSTRALIA ;
(8) University Malaya Medical Center, KUALA LUMPUR, MALAYSIA ; (9) Sarawak General
Hospital, SARAWAK, MALAYSIA ; (10) National University Hospital, SINGAPORE,
SINGAPORE ; (11) Serdang Hospital, SERDANG, MALAYSIA ; (12) National Heart Center
Singapore, SINGAPORE, SINGAPORE
ID42
Beacon II - a prospective, multi-centre, observational, real-world registry to
assess clinical outcomes of patients after treatment with the BioMatrix stent
SANTOSO T.(1), DENG X.W.(2), ZHANG X.M.(2), LIM V.(3), TRESUKOSOL D.(4), PHAM
M.H.(5), QUANG HUAN D.(6)
(1) Medistra Hospital, JAKARTA, INDONESIA ; (2) Kiang Wu Hospital, MACAO, MACAO ;
(3) National Heart Center, SINGAPORE, MALAYSIA ; (4) Siriraj Hospital, BANGKOK,
THAILAND ; (5) Vietnam Heart Institute, HANOI, VIETNAM ; (6) Heart institute of HCMC,
HO CHI MINH, VIETNAM
Effect of oral feeding of allium ascalunicom l. in thorasic aortia contractil response...
FALLAHI F.
Shahed university - cardiology department, TEHRAN, IRAN
ID43
Percutaneous coronary intervention in patients with chronic total occlusion: CACTO
(Complex Angioplasty & CTO Intervention Society - India) interventional data
HORE D., VITHALA S., PLN K., SHAHA K.
Global Hospitals, HYDERABAD, INDIA
Final Programme / 12th-14th January, 2012 / Singapore
10
Interviews with last year's prize winners
Interview with Yoshiaki Mitsutake
Interview with Kin-Lam Tsui
Clinical case winner 2011 and Assistant
Professor of Cardiovascular Medicine in the Department
of Internal Medicine at Kurume University School of Medicine,
Japan
How should I treat? case winner 2011,
Director of the Cardiac Catheterisation Laboratory
of Pamela Youde Nethersole Eastern Hospital,
Hong Kong
What was the subject of your case?
My case title is “A juvenile with severe stenosis at the bilateral coronary
artery ostium.” This was the case of a 15-year-old girl who presented
with unstable angina. Her coronary angiogram revealed severe stenosis
at the bilateral coronary artery ostium. We had the choice of implanting
stents into her ostial lesions, but we considered the effects of long-term
dual anti-platelet therapy to this young girl and finally selected CABG
for her treatment. Afterwards, we performed VH-IVUS and OCT to
evaluate the ostial lesions.
Can you introduce yourself to the community?
I am a Consultant Cardiologist and the Director of the Cardiac Catheterisation Laboratory of Pamela Youde Nethersole Eastern Hospital, Hong
Kong. In AsiaPCR/SingLIVE 2011, I submitted the case titled "Left main
stenosis and two CTOs in a patient with NSTEMI and cardiogenic shock"
to the "How should I treat?" session.
What was the subject of your case?
The case highlighted the dilemma in choosing the optimal revascularisation
strategy in this setting of acute coronary syndrome.
The complex anatomy together with the unstable haemodynamic made
PCI unfavourable and undoubtedly high-risk. On the other hand, PCI
offered a prompt way for revascularisation and saving the patient.
Why did you submit this case?
Coronary ostial stenosis involving both coronary ostia is a rare occurrence. There have been few reports of bilateral coronary ostial stenosis
in young subjects without known conventional coronary risk factors.
In the absence of conventional coronary risk factors, coronary ostial
narrowing has been reported in fibromuscular dysplasia, syphilitic
aortitis, postradiation and Takayasu’s arteritis without any recognisable
etiological background. Unfortunately, we could not identify the
mechanism of our patient’s ostial lesions by blood, angiographic,
intravascular imaging studies or pathological evaluation of the specimen
obtained during surgery. However, we think one of the causes of
sudden death in juveniles might be severe cardiac ischemia induced by
coronary artery disease as in this case.
What were the positive effects from winning the award?
The "How should I treat?" session provided a good platform for fruitful
discussion and an exchange of ideas among expert panellists from
various regions.
I was glad that the case attracted positive feedback and that I was
awarded the Best "How Should I Treat?" Award.
It encouraged me to further participate in interactive sessions of this
kind. When the "How Should I Treat?" session was subsequently
introduced in one of our regional meetings in collaboration with
EuroPCR, I contributed to raise another complex case for discussion.
What were the positive effects from winning the award?
Winning this award has given me greater confidence in presenting data
at international conferences.
Do you recommend that your peers submit?
I would certainly recommend to my peers to participate in this meaningful
activity.
Do you recommend that your peers submit?
Yes, I do.
What do you gain from AsiaPCR/SingLIVE?
AsiaPCR/SingLIVE is definitely among the most educational and
successful meetings held in Asia that allows participants to keep abreast
of the developments in the field of interventional cardiology.
What do you gain from AsiaPCR/SingLIVE?
Through AsiaPCR/SingLIVE, I am able to build international collaborations.
PCR courses are made by and for you!
Your daily practice is that of many others - that’s
why the Interactive Case Corner is pivotal to the
entire community before, during, and after the
Course.
PCR Courses are made by and for the cardiovascular
community starting with your case submissions,
but your input reaches a community above and
beyond the Course.
Course
Call for
at PCRonline.com
Before
During
After
You submit your case
You share your work with a small group
You share it with the entire community
PCRonline publishes PCR London Valves, AsiaPCR/SingLIVE, GulfPCR-GIM and EuroPCR cases.
One year on the Interactive Case Corner section has seen:
2 89,997 pages viewed
2 13,019 visits
2 Average of 25 minutes spent per visit
AsiaPCR/SingLIVE 2011 Complications hits:
pages viewed
20,722
Next week, all the cases presented at AsiaPCR/SingLIVE will be online, join in the discussion!
11 Final Programme / 12th-14th January, 2012 / Singapore
Interview
Interview with Jack Tan Wei Chieh
Guest Faculty, Cardiology Consultant with the Department of Cardiology
and Director of the Coronary Care Unit at the National Heart Centre Singapore
What is the disease pattern and burden of structural heart
disease in Singapore?
The demographics of the Singapore population is rapidly aging. By the
year 2030, 19% of the population will be aged >65 years old in
comparison to the current 7%. The most common and impactful
structural disease will be degenerative aortic stenosis, affecting around
8% of individuals over 80 years of age. My guess is that around 3050% of such patients in Singapore with significant and symptomatic
aortic stenosis do not receive surgical aortic valve replacement due to
the high risk or to the patient’s reluctance for open surgical treatment.
The most common structural heart disease is probably Mitral Valve
Prolapse [MVP] with a reported prevalence to be around 5-15% in the
general population. The mean and median age at presentation/detection
in our local population is 42 and 38 years respectively. The population
of patients who develop complications of MVP requiring surgical treatment is substantially lower at around 3% after initial detection during
a mean follow up period of nine months. Treatment locally has been
surgical mitral valve repair with a high success rate in patients with
low surgical risk. Functional Mitral Regurgitation [MR] continues to
increase in prevalence as survival for patients with impaired left
ventricular systolic function improves. Isolated surgical repair for
functional MR is rarely performed due to the patient co-morbidity and
lack of demonstrable survival benefits.
Rheumatic heart disease continues to contribute a small percentage
of the structural heart disease in Singapore as the country has moved
past third world status over the last few decades. Percutaneous transvenous mitral commissurotomy for mitral stenosis continues to be
performed at our centre but at relatively infrequent intervals.
There was an increasing trend of abortion for birth defects, accompanied by a falling trend in the congenital anomalies of live births due
to early antenatal detection in Singapore. The most common of which
continues to be cardiac at 9.07 per 1,000 live births. Atrial septal
defects continue to be the most common congenital heart disease
and since transcatheter device closure was introduced in Singapore in
1997, it has been the preferred choice over surgery for anatomically
suitable patients. The favoured local device is the Amplatzer septal
occluder.
Tell us about the percutaneous valves intervention programmes
(TAVI and MitraClip) in Singapore
TAVI and the MitraClip procedures were adopted as the first in Asia
at our centre in February 2009 and April 2011 respectively.
Both programmes are multidisciplinary in nature and have surgeons,
anaesthetists, interventional and echo cardiologists on the team. Both
programmes currently select high-risk surgical patients deemed not
suitable for open surgery by at least two surgeons and cases are
discussed at our cardiac conferences. Our TAVI programme uses the
CoreValve and the Edwards Sapian. Both transfemoral and transapical
modes are employed. The initial 10 tens had two deaths from vascular
and deployment complications using the older generation larger 22F
Edwards sheath delivery system. The CoreValve system was adopted
later. The later cases had a lower complication rate after the initial
learning curve and better patient selection in our local population.
Smaller built and vascular access challenges are true for our Asian
population especially in elderly females. Eleven MitraClip cases have
been successfully performed since April 2011 with no peri-procedural
mortality. The majority of cases were performed for functional MR.
Degenerative MR cases generally required a greater frequency of
2-clip deployment compared to functional MR. All patients had at least
improved one functional New York Heart Association class status.
Both programmes offer a gratifying treatment route for symptomatic
non-surgical candidates. However, the high costs of treatment
currently continue to limit widespread adoption.
Do you think the number of TAVI cases will overtake surgical
TAVI - And if so, why?
I think the number of TAVI cases will overtake surgical TAVI because
the sheath delivery sizes will continue to decrease with improved
controlled deployment and repositionable devices on the horizon.
What do you think of the future of devices in both AF and hypertension?
Atrial fibrillation will inexorably continue to increase in prevalence as
our population ages. The spectrum of devices available for atrial
fibrillation includes pacing, ablation and atrial appendage occluders.
New dedicated electrophysiology catheters and instruments for
percutaneous or open surgical MAZE that increase successful rates in
an idiotic proof and likely operative independent manner would be
welcome.
The tools available to a surgeon for curative AF treatment as a run-by
shooting during concomitant coronary bypass and valve surgery
are in need forbetter development for widespread adoption. Atrial
appendage occluders, I think, will continue to be a niche area as the
rapid adoption of effective and relatively safe use of oral, reversible
direct thrombin inhibitors continue, unless the cost is contained within
a routine AF ablation.
New non-pharmacological therapies for hypertension continue to
excite. Renal denervation through a minimally invasive approach using
the Ardian Symplicity device appears to be safe in the short term with
a low incidence of local complications and highly effective for resistant
cases.
If the effects were proven to be durable, the scopes of devices that
would enter the market would be overwhelming due to the huge size
of the market. The indications might also expand as more studies are
on going for heart failure, cardio-renal syndrome, obstructive sleep
apnoea, chronic renal failure, etc.
Baroreflex activation devices that consist of a pulse generator and
carotid-sinus leads that can lower blood pressure through stimulation
of carotid baroreflex receptors, need to be proven as an effective
therapy and might be more useful as a personalised anti-hypertensive
adjunct for select patients.
What do you think of AsiaPCR/SingLIVE and what is your vision
for the future of the Course?
The Course has been a happy marriage between our Centre and our
European colleagues. Beyond overcoming cultural and time zone
differences in working together, I believe we have benefited precisely
because of these differences and exchange of expertise.
The challenge for AsiaPCR/SingLIVE has always been to appeal to the
varied audience that comes from surrounding regional countries with
different cultures and practicing milieus. Now we also need to be
cognisant of the increasing rate of attendees from varied European
countries.
I think the future of the Course lies in its relevance and ability to impart
the simple and to adopt treatment guidelines in demonstrative cases
that are inherently picked up across all cultural differences.
Final Programme / 12th-14th January, 2012 / Singapore
12
Programme at a glance
Thursday 12th
Main
Arena
09:00
10:00
11:00
09:30
10:30
11:30
Welcome
Opening
& live
Live
ceremony & How should
demonstration
Perspectives I treat? demonstration
from
from
India
on...
Singapore
12:00
13:00
12:30
13:30
14:00
Room 2
Room 3
What's new in transradial
interventions
Room 201
Nurse/Technician
Radiographer programme
Abstracts
PCI and ACS
16:00
15:30
Live
Late
demonstration
breaking
from
trials
Singapore
Sponsored lunch
symposium
Abbott Vascular
Topic: PCI in patients with complex left main disease
Technical
aspects of
ASD/PFO
closure
15:00
14:30
How
should
I treat?
16:30
17:00
17:30
Live
The most
demonstration educational
from India
cases
18:00
Wrap-up
08:30
Perspectives
on...
08:00
Most educational
case
Wrap-up
07:30
18:30
19:00
19:30
20:00
Sponsored dinner symposium
Biosensors International
TOPIC: Complex PCI in patients with difficult subsets
Renal
denervation
for resistant
hypertension
treatment
Sponsored lunch
symposium
Minvasys
Aortic balloon
valvuloplasty: a
bridge to TAVI
LTT on transcatheter
aortic valve
implantation
Nurses, technicians
and radiographers
forum - PART I
Clinical case submissions
forum I
Sponsored dinner symposium
Eurocor
Abstracts
Imaging
PCI tips & tricks
Update on
vascular closure
devices
Nurses, technicians
and radiographers forum - PART II
Friday 13th
Live
demonstration
from China
Main
Arena
10:00
11:00
10:30
11:30
12:00
The most
Live
demonstration educational
cases
from China
How
should I
treat?
13:00
12:30
13:30
14:00
Sponsored
lunch symposium
Terumo
TOPIC: PCI in patients with high-risk acute coronary syndrome
Sponsored
breakfast
symposium
Room 2
Sponsored
lunch symposium
Maquet
Transcatheter mitral
interventions
Sponsored
lunch symposium
Hexacath
Medtronic
Sponsored
breakfast
symposium
Meril Life
Sciences
Room 3
LTT on transseptal
puncture techniques
16:00
15:30
16:30
Live
demonstration
from
Singapore
How
should I
treat?
Left atrial
appendage
Percutaneous
closure in
paravalvular
patients with
leak closure
atrial fibrillation
Meet the
experts
Room 201
Stent
complications
High-risk acute
coronary
syndrome
My most
educational
case
17:30
18:00
Live
demonstration
from
Indonesia
18:30
19:00
Complications forum
Update on invasive coronary imaging and functional lesion
assessment (IVUS/OCT/FFR)
PART 1
Meet the
experts
Meet the
experts
17:00
TOPIC: PCI in patients with complex bifurcation lesion
Abstracts
Structural heart
disease
Clinical case
submissions forum II
15:00
14:30
Live
demonstration
from
Indonesia
Wrap-up
09:30
The most
educational
cases
09:00
Perspectives
on…
08:30
Wrap-up
Chien Foundation
Lectureship
08:00
Perspectives
on…
07:30
How to write
a paper
PART 2
Clinical case submissions
forum III
Abstracts
PCI and bifurcation stenting
How to prepare and
deliver an efficient
PowerPoint
presentation
Room 208
Room 209
Imaging
programme
Guiding intervention with imaging: Viability imaging:
which test?
time for a re-think?
Multimodality imaging for
valvular interventions
Imaging in the
emergency department
Saturday 14th
09:00
09:30
Live
demonstration
from
Singapore
10:00
10:30
11:00
11:30
12:00
Live
Live
How
How
demonstration
demonstration
should I
should I
from
from
treat?
treat?
Singapore
Singapore
TOPIC: Non-coronary transcatheter interventions
Main
Arena
Room 2
Room 209
Endovascular
Endovascular case forum
programme
Sharing experience on coronary chronic
total occlusion with experts
New horizons in lower limb
interventions
Coronary / Structural heart / Hypertension
13:00
12:30
13:30
14:00
14:30
My most educational case:
learn from the experts
15:00
15:30
16:00
16:30
17:00
Awards and
closing ceremony
08:30
Keynote lecture
08:00
Perspectives
on…
07:30
Interactive case-based
review discussion
Aortic aneurysm- evolving
endovascular techniques
Sponsored
Daily Programme
/ 11th-12th October,
/ 12th-14th2010
January,
/ London
2012 / Singapore
13 Final
How should I treat?
Renal interventions:
My worst nightmare:
the end of renal artery
complications session
revascularisation?
Nurse, Technician, Radiographer
Imaging
Endovascular
Coronary / Structural / Hypertension scientific programme
Thursday 12th
11:50-12:05
MAIN ARENA
08:40-12:10
MORNING TOPIC
PCI in patients with complex left main disease in 2012 and beyond
Objectives:
▸ To have a better understanding of the latest data
▸ To understand the specific indications for left main PCI
in the Asia-Pacific region
▸ To learn the different left main stenting strategies
08:40-09:30
Live demonstration
Welcome and live demonstration from the National Heart Centre
Singapore
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys
▸ Welcome - T.H. Koh
08:45-09:30 Live demonstration from the National Heart Centre Singapore
09:30-10:00
Opening ceremony
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys
▸ Presentation of the Course and today's programme - T.H. Koh
▸ PCR family - J. Marco
▸ The three tools for coronary artery which I'm dreaming of - P.W. Serruys
10:00-10:20
Mini debate
Perspectives on PCI in patients with complex left main disease
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: J.J. Cheng, R. Gao, U. Kaul, J. Marco, M.C. Morice, P.W. Serruys
▸ Setting the stage - M.C. Morice
▸ My practice - R. Gao
▸ My practice - M.C. Morice
▸ My practice - U. Kaul
▸ What we have learned - T.H. Koh
10:20-11:05
How should I treat? session
How should I treat? - PCI in patients with complex left main disease
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith,
Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari
▸ Introduction - E. Eeckhout
▸ Case presentation - W.Y. Guo
▸ How would I treat? - M.A. Rosli
▸ How would I treat? - T.H. Ahn
▸ How did I treat? - W.Y. Guo
▸ Discussion
▸ Consensus - T.H. Koh
11:05-11:50
Live demonstration
Live demonstration from Medanta Medicity, Gurgaon, India
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith,
Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari
“Call for” based session
The most educational case on PCI in patients with complex left main
disease
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith,
Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari
▸ Severe left main distal stenosis treated by a new-dedicated bifurcation DES
- J. Berland
▸ Discussion
12:05-12:10
Wrap-up
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: T.H. Ahn, A. Colombo, R. Gao, W.Y. Guo, A. Mehta, I. Meredith,
Q.T. Nguyen, M.A. Rosli, T. Santoso, R. Zambahari
▸ What we have learned today on PCI in patients with complex left main
disease - W. Udayachalerm
12:15-13:30
Industry-supported session
Are we ready to change?
With an unrestricted educational grant from Abbott Vascular
Chairpersons: T.H. Koh, J. Marco
Panellists: M.W. Krucoff, S.T. Lim, P. Ong, P.W. Serruys, H.C. Tan
▸ Introduction and objectives - T.H. Koh
▸ Is newer always better? - M.W. Krucoff
▸ Can we reduce dual antiplatelet therapy (DAPT) to optimise PCI? - H.C. Tan
▸ Are we ready for vascular restoration therapy? - P.W. Serruys
▸ Discussion
▸ Take-home message - J. Marco
13:50-14:30
Late breaking trial session
Late breaking trials
Chairperson: J. Marco
Co-chairperson: T.H. Koh
Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman,
M. Munawar, C.K. Naber, D. Tresukosol, W.A. Wan Azman
▸ Introduction - T.H. Koh
▸ The BASE-acute coronary syndrome trial: 18-month follow-up - P. Karjalainen
▸ Discussion
▸ INDICOR: the Paclitaxel-Eluting PTCA-balloon catheter in combination with a
cobalt-chromium stent to treat coronary artery disease in a real world scenario
- U. Kaul
▸ Discussion
▸ Summary - J. Marco
14:30-17:55
AFTERNOON TOPIC
Complex PCI in patients with difficult subsets in 2012 and beyond
Objective:
▸ To understand the best management revascularisation strategy for
patients with:
- depressed LV function
- impaired renal function
- calcified/diffused lesions
14:30-15:15
Live demonstration
Live demonstration from the National Heart Centre Singapore
Chairperson: J. Marco
Co-chairperson: T.H. Koh
Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman,
M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
14
Coronary / Structural / Hypertension scientific programme
Thursday 12th - Main Arena
15:15-15:35
Mini debate
Perspectives on complex PCI in patients with difficult subsets
Chairperson: J. Marco
Co-chairperson: T.H. Koh
Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman,
M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman
▸ Setting the stage - C.K. Naber
▸ My practice - S. Sumitsuji
▸ My practice - C.K. Naber
▸ My practice - N.A.M. Momenuzzaman
▸ What we have learned - J. Marco
15:35-16:15
How should I treat? session
How should I treat? - Complex PCI in patients with difficult subsets
Chairperson: J. Marco
Co-chairperson: T.H. Koh
Panellists: K.T. Chan, T. Cuisset, D.S. Gambhir, N.A.M. Momenuzzaman,
M. Munawar, C.K. Naber, S. Sumitsuji, D. Tresukosol, W.A. Wan Azman
▸ Case presentation - T. Cuisset
▸ How would I treat? - K.T. Chan
▸ How would I treat? - D.S. Gambhir
▸ How did I treat? - T. Cuisset
▸ Discussion
▸ Consensus - J. Marco
Industry-supported session
Does BA9 technology benefit your patients long-term?
With an unrestricted educational grant from Biosensors International
Chairpersons: T. Santoso, P.W. Serruys
Panellists: K.T. Chan, F.H. Jafary, M. Munawar, A. Rosman, R. Tangco, C.J. Wu
Objectives:
▸ To understand the impact of technology and its potential advantage on patient
safety
▸ To educate on patient selection and the clinical relevance in daily practice
▸ To understand the unique application of a self-expanding dedicated bifurcation
drug-eluting stent
18:00-18:30 Dinner
▸ Welcome and opening remarks - P.W. Serruys
▸ Lessons from BioMatrix and the BEACON II registry at three years - D. Tresukosol
▸ Very long-term outcomes with Biolimus A9 from an all-comers randomised
clinical trial: LEADERS four-year data - P.W. Serruys
▸ Where dedicated bifurcation stents can benefit your patients: Axxess - the selfexpanding bifurcation Biolimus A9 eluting stent - S. Verheye
▸ Axxess case review: the first Asian experience - M.A. Rosli
▸ Axxess case review: the first Asian experience - C.Y.R. Fung
▸ Discussion
▸ Take-home message - T. Santoso
ROOM 2
16:20-17:05
Live demonstration
Live demonstration from Medanta Medicity, Gurgaon, India
Chairperson: P.W. Serruys
Co-chairperson: J.J. Cheng
Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han,
M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu
17:05-17:50
18:00-20:00
“Call for” based session
The most educational cases on complex PCI in patients with difficult
subsets
Chairperson: P.W. Serruys
Co-chairperson: J.J. Cheng
Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han,
M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu
▸ When surgery won't cut it...a complex problem with a percutaneous
solution - P. Jain
▸ Discussion
▸ A small size isn't enough - M. Cardenas
▸ Discussion
▸ Intravascular ultrasound guided percutaneous coronary intervention with
minimum contrast media - K. Kamishima
▸ Discussion
17:50-17:55
Wrap-up
Chairperson: P.W. Serruys
Co-chairperson: J.J. Cheng
Panellists: P. Agarwal, J. Berland, S.L. Chen, H.C. Gwon, Y.L. Han,
M.W. Krucoff, F. Mauri, M. Ochiai, W. Udayachalerm, C.J. Wu
▸ What we have learned today on complex PCI in patients with difficult
subsets - T.H.S. Lo
Programme valid as of 28/12/2011. Subject to modification.
15 Final Programme / 12th-14th January, 2012 / Singapore
10:15-11:05
Technical aspects of ASD/PFO closure
Chairperson: J. Yip
Co-chairperson: N.Q. Nguyen
Panellists: A. Al Shafi Majumder, F. Kleber, H. Mehta, G. Sengottuvelu, R. Sethi,
K.H. Srinivasa
Objectives:
▸ To learn the different types of closure devices
▸ To learn about the different approaches of ASD closure
▸ To understand the current limitations and issues
▸ Introduction - J. Yip
▸ Overview of ASD/PFO closures - F. Kleber
▸ Complications from ASD implants - O. Muller
▸ Case presentation of complex ASD/PFO closures - L.H. Nguyen
▸ Case presentation of complex ASD/PFO closures - J.L. Tan
▸ Discussion
11:10-12:10
“Call for” based session
PCI and acute coronary syndrome
Chairperson: A. Wong
Co-chairperson: H. Suryapranata
Panellists: T. Ahmed, A. Erglis, I.C. Hsieh, S.W. Kyaw
▸ Introduction - A. Wong
▸ Efficacy of STEMI network in Southern Taiwan, a 3-year follow-up study - F.Y. Kuo
▸ Statin use decreased short-term and long-term major adverse cardiac events in
acute myocardial infarction in patients with renal insufficiency - S.Y. Lim
▸ Comparison of clinical characteristics, 1-year readmission rates, cost and
mortality amongst patients undergoing percutaneous coronary intervention for
stable angina, acute coronary syndromes and ST-elevation myocardial
infarction - K.K. Yeo
▸ Clinical characteristics and 1-year readmission rates, length of stay, cost and
mortality in patients among men and women undergoing percutaneous
coronary intervention - J.M. Fam
▸ Feasibility and safety of the 3Fr guiding sheath in percutaneous coronary
interventions - D. Tonomura
▸ Take-home message - H. Suryapranata
Coronary / Structural / Hypertension scientific programme
Thursday 12th - Room 2
12:15-13:30
Industry-supported session
Bifurcation dilemmas: case discussion on different treatment strategies
With an unrestricted educational grant from Minvasys
Chairperson: J. Fajadet
Panellists: J. Berland, Y.S. Chong, D. Desai, B. Garcia Del Blanco, S.M. Hiremath
Objectives:
▸ To understand the importance of being able to shift technical strategy during the
procedure
▸ To assess the benefits of a provisional approach
▸ To understand the need for a dedicated stent design
▸ Introduction and objectives - J. Fajadet
▸ Bifurcations: be ready to modify your initial treatment strategy - S.M. Hiremath
▸ A complex bifurcation lesion case: options, discussion and solution
B. Garcia Del Blanco
▸ A Medina 1,1,1 case: options, discussion and solution - D. Desai
▸ A left main case: options, discussion and solution - J. Berland
▸ Discussion
▸ Take-home message - J. Fajadet
14:00-14:50
Renal denervation for resistant hypertension treatment
Chairperson: C.M. Chan
Co-chairperson: S. Shetty
Panellists: C.T. Chin, R. Khurana, S.S.L. Li, R. Zambahari
Objectives:
▸ To understand the rationale for renal denervation in hypertension
▸ To have a critical overview of current data
▸ To learn on technical aspects
▸ Introduction - C.M. Chan
▸ Anatomy and physiology of the renal innervation - C.M. Chan
▸ Technical steps in renal denervation - S. Shetty
▸ Patient selection and data - R. Zambahari
▸ Case presentation of renal denervation - S.T. Lim
▸ Discussion
16:30-17:55
“Call for” based session
Imaging
Chairperson: T. Akasaka
Co-chairperson: I. Meredith
Panellists: J. Escaned, K.H. Lam, R. Thachathodiyl
▸ Introduction and objectives - T. Akasaka
▸ Optical coherence tomography assessment for Biolimus-eluting stents and
Everolimus-eluting stents in the very early period - S. Kuramitsu
▸ Optical coherence tomography analysis for restenosis of Everolimus-eluting stents
in comparison with bare metal stents and Paclitaxel-eluting stents - S. Enomoto
▸ Difference of neointimal appearance between early and late restenosis after
Sirolimus-eluting stent implantation assessed by optical coherence tomography
- H. Sougawa
▸ Relationship between systemic levels of inflammatory biomarkers and coronary
artery thin-capped fibroatheroma - R. Tazaki
▸ Clinical impact of small-sized stent mal-apposition after stent implantation as
detected by optical coherence tomography - A. Taruya
▸ Neointimal changes during an extended period after bare metal stent implantation:
insights from integrated Backscatter Intravascular ultrasound - T. Haraguchi
▸ Dual axis rotational coronary angiography - the preferred mode of coronary
angiography? - C.P. Lim
▸ Take-home message - I. Meredith
18:00-19:40
Industry-supported session
Drug-eluting balloons - a viable alternative in PCI
With an unrestricted educational grant from Eurocor
Chairpersons: F. Malik, H.C. Tan
Panellists: Y.S. Chong, R. Gotabhaya, A. Khan, S. Mohd Ali
Objective:
▸ To understand and draw consensus on the use of drug-eluting balloons in
expanding indications
▸ Introduction - F. Malik
▸ Technology behind a drug-eluting balloon - D. Dudek
▸ Drug-eluting balloon - the ideal indications - R. Khurana
18:25-19:10 Live demonstration from Apollo Hospitals, Hyderabad, India
14:55-16:25
“Call for” based session
PCI tips and tricks
Chairperson: S.T. Lim
Co-chairperson: B. Chevalier
Panellists: S. Dhakam, B. Hanif, O. Maskon, T.K. Ong, S. Rifqi
Objectives:
▸ To learn tips and tricks from experts on how to avoid or resolve issues
▸ To learn how to improve manipulation of tools
▸ Introduction - S.T. Lim
▸ Coronary chronic total occlusion with two sesame doors - Y.S. Chong
▸ A novel way to manage oscillating/rocking/pulsating stent during PCI - S. Aziz
▸ A price to pay - M. Cardenas
▸ Intravascular ultrasound guided percutaneous coronary intervention with
minimum contrast media - K. Kamishima
▸ Tips & tricks in CTO (antegrade approach) - A. Mehta
▸ Take-home message - B. Chevalier
▸ The clinical evidence - C.K. Naber
▸ Freeway - management of critical limb ischemia - B. Chua
▸ Discussion
▸ Take-home message - H.C. Tan
ROOM 3
10:15-12:05
What's new in transradial interventions
Chairperson: J. Fajadet
Co-chairperson: C.J. Wu
Panellists: F. Mauri, S. Mithrakumar, M. Munawar, O. Sakhov
Objectives:
▸ To learn the current approach of TRI
▸ To appreciate the new developments in TRI
▸ Overview of current indications of TRI vs. TFI - O. Varenne
▸ Transulnar PCI - T.M. Patel
▸ Sheathless TRI - S. Sumitsuji
▸ Top 10 tips and tricks for TRI - C.J. Wu
▸ Complications of TRI - J. Fajadet
▸ Discussion
▸ Case presentation of TRI - W.A. Wan Azman
▸ Case presentation of TRI - B. Zhang
▸ Case presentation of TRI - A. Low
▸ Discussion
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
16
Coronary / Structural / Hypertension scientific programme
Thursday 12th - Room 3
14:00-14:55
Aortic balloon valvuloplasty: a bridge to TAVI
Chairperson: G. Manoharan
Panellists: C. Chan, M. Lee, M.A. Rosli, J.L. Soon, N. Wongpraparut
Objectives:
▸ To understand when to perform BAV and lessons learned
▸ To learn technical aspects of the procedure
▸ Case selection and indications for balloon aortic valvuloplasty - R.I. Low
▸ How I do it - M. Thomas
▸ How I do it - P. Chiam
▸ Avoid and manage complications of balloon aortic valvuloplasty - E. Grube
▸ Discussion
15:10-16:40
LTT on transcatheter aortic valve implantation
Facilitators: J. Fajadet, M. Thomas
Panellists: E. Grube, M. Lee, G. Manoharan
Objectives:
▸ To understand the current indications of TAVI and outcomes
▸ To learn technical aspects and issues of TAVI
Live in-a-box®
16:55-17:55
MAIN ARENA
08:30-12:00
MORNING TOPIC
PCI in patients with high-risk acute coronary syndrome in 2012 and
beyond
Objectives:
▸ To understand the current strategic approaches to high-risk
acute coronary syndrome
▸ To understand how to integrate the new antiplatelet and
antithrombotic agents in decision making in the Asia-Pacific
region
▸ To understand the technical strategy for STEMI patients
08:30-09:20
Live demonstration
Live demonstration from Shanghai Institute of Cardiovascular Diseases,
Shanghai, China
Chairperson: M.C. Morice
Co-chairperson: T.H. Koh
Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen,
A. Ong, A. Rahman, D. Walters
▸ Introduction - M.C. Morice
Update on vascular closure devices
Chairperson: K.K. Yeo
Co-chairperson: G. Manoharan
Panellists: S. Kum, M. Lim, S. Shetty, Y.K.K. Sin, S.G. Teo
Objectives:
▸ To learn the various techniques of vascular access closure
▸ To learn how to avoid complications during vascular closure
▸ Collagen closure devices - K.K. Yeo
▸ Suture closure devices - J. Tan
▸ Complications of closure devices - M.C. Morice
▸ Device closure for large bore cannulations - G. Manoharan
▸ Discussion
ROOM 201
10:15-12:15
Friday 13th
“Call for” based session
Clinical case submissions forum I
Chairperson: K-H. Sim
Co-chairperson: P. Karjalainen
Panellists: R. Tangco, H. Trisnohadi
▸ A jailed coronary chronic total occlusion lesion - C.Y.R. Fung
▸ Double vessel stenting via 5 French diagnostic catheters using a new stent-on-awire - N. Shrestha
▸ VSD closure device - V. Kumar
▸ Right coronary artery CTO stenting in situs inversus dextrocardia - radial
approach - S.S.R. Parupati
▸ A successful case of transradial PCI using microcatheter (ASAHI Corsair) and
tapered-tip guidewire (Wizard 3) for tortuous right coronary artery coronary
chronic total occlusion lesion - T. Yaguchi
▸ High risk left main bifurcation intervention - S. Wafa
▸ I wouldn't be alive (left main thromboaspiration) - K. Chhatrapati
▸ Triple vessel occlusion with no distal flow - O.K. George
▸ Through the rocks - A. Jain
▸ Lesion or no lesion - B. Pakshirajan
Programme valid as of 28/12/2011. Subject to modification.
17 Final Programme / 12th-14th January, 2012 / Singapore
08:35-09:20 Live demonstration from Shanghai Institute of Cardiovascular
Diseases, Shanghai, China
09:20-09:40
Mini debate
Perspectives on PCI in patients with high-risk acute coronary syndrome
Chairperson: M.C. Morice
Co-chairperson: T.H. Koh
Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen,
A. Ong, A. Rahman, D. Walters
▸ Setting the stage - T. Cuisset
▸ My practice - A. Ong
▸ My practice - T. Cuisset
▸ My practice - Q.T. Nguyen
▸ What we have learned - M.C. Morice
09:40-10:20
How should I treat? session
How should I treat? - PCI in patients with high-risk acute coronary
syndrome
Chairperson: M.C. Morice
Co-chairperson: T.H. Koh
Panellists: T. Cuisset, S. Kar, T.H.S. Lo, R.I. Low, S. Nakamura, Q.T. Nguyen,
A. Ong, A. Rahman, D. Walters
▸ Case presentation - D. Walters
▸ How would I treat? - A. Rahman
▸ How would I treat? - Q.T. Nguyen
▸ How did I treat? - D. Walters
▸ Discussion
▸ Consensus - T.H. Koh
10:25-11:10
Live demonstration
Live demonstration from Shanghai Institute of Cardiovascular Diseases,
Shanghai, China
Chairperson: I. Meredith
Co-chairperson: S.T. Lim
Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne,
S. Verheye
Coronary / Structural / Hypertension scientific programme
Friday 13th - Main Arena
11:10-11:55
“Call for” based session
The most educational cases on PCI in patients with high-risk acute
coronary syndrome
Chairperson: I. Meredith
Co-chairperson: S.T. Lim
Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne,
S. Verheye
▸ Resolution of intractable thrombus in DES - H. Hashidomi
▸ Discussion
▸ Do all LMCA occlusions require stenting/CABG? - R. Khaja
▸ Discussion
▸ An unusual case of acute coronary syndrome in a young lady - O. Muller
▸ Discussion
11:55-12:00
Wrap-up
Chairperson: I. Meredith
Co-chairperson: S.T. Lim
Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, O. Varenne,
S. Verheye
▸ What we have learned today on PCI in patients with high-risk acute
coronary syndrome - M.A. Rosli
14:50-15:10
Mini debate
Perspectives on PCI in patients with complex bifurcation lesion
Chairperson: H.C. Tan
Panellists: I.H. Chae, J.L Chen, W.Y. Guo, B. Chevalier, A. Colombo, F. Kleber,
T.S. Kler, M. Nakamura, A. Pathan, A. Rahman
▸ Setting the stage - A. Colombo
▸ My practice - W.Y. Guo
▸ My practice - A. Colombo
▸ My practice - M. Nakamura
▸ What we have learned - H.C. Tan
15:10-15:50
How should I treat? session
How should I treat? - PCI in patients with complex bifurcation lesion
Chairperson: H.C. Tan
Panellists: I.H. Chae, J.L Chen, W.Y. Guo, B. Chevalier, A. Colombo, F. Kleber,
T.S. Kler, M. Nakamura, A. Pathan, A. Rahman
▸ Case presentation - J.L Chen
▸ How would I treat? - F. Kleber
▸ How would I treat? - A. Pathan
▸ How did I treat? - J.L Chen
▸ Discussion
▸ Consensus - H.C. Tan
12:00-12:10
15:55-16:40
Chien Foundation Lectureship
Chairperson: I. Meredith
Co-chairperson: S.T. Lim
Panellists: J.L Chen, J.C.Y. Chou, U. Kaul, F. Malik, T. Muramatsu, S. Verheye,
O. Varenne
Live demonstration from the National Heart Centre Singapore
Chairperson: R. Ng
Co-chairperson: C.K. Naber
Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito,
S.C. Ng, P.W. Serruys, A.F. Yahya
12:15-14:00
16:40-17:10
Industry-supported session
Left main trunk and bifurcation - basics to practices
With an unrestricted educational grant from Terumo Corporation
Chairpersons: M.C. Morice, T.H. Koh
Panellists: B. Chevalier, K.H. Lam, A. Low, F. Malik, T. Matsubara, G. Nakazawa,
Y. Oikawa, T. Santoso, T. Yamashita, F. Yoshimachi
Objectives:
▸ To understand left main trunk and bifurcation lesions histopathologically and
the guidelines of procedure
▸ To learn tips and tricks through a live demonstration
▸ To reflect the knowledge gained of optimal procedure to daily practice
▸ Introduction and objectives - T.H. Koh
▸ Left main trunk and bifurcation: histopathological view - G. Nakazawa
▸ Current guidelines of left main trunk and bifurcation intervention - B. Chevalier
Live demonstration
“Call for” based session
The most educational cases on PCI in patients with complex bifurcation
lesion
Chairperson: R. Ng
Co-chairperson: C.K. Naber
Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito,
S.C. Ng, P.W. Serruys, A.F. Yahya
▸ PCI of a critical bifurcating ostial stenosis of a dominant right coronary
artery, involving the origin of large aberrant left circumflex - S. Aziz
▸ Discussion
▸ Rescue bifurcation angioplasty of a calcified left anterior
descending/tortuous angulated diagonal lesion for cardiogenic shock in the
setting of multiple comorbidities - S. Kubba
▸ Discussion
12:40-13:25 Live demonstration from the National Heart Centre Singapore
17:10-17:55
▸ Drug-eluting stent for left main trunk and bifurcation (data from NOBORI 2)
- T. Santoso
▸ Case review of left main trunk and bifurcation - Y. Oikawa
▸ Discussion
▸ Take-home message - M.C. Morice
Live demonstration from Harapan Kita, Jakarta, Indonesia
Chairperson: R. Ng
Co-chairperson: C.K. Naber
Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito,
S.C. Ng, P.W. Serruys, A.F. Yahya
14:05-18:00
AFTERNOON TOPIC
PCI in patients with complex bifurcation lesion in 2012 and beyond
Objectives:
▸ To understand how to implement the latest data in decision
making for patients with complex bifurcation lesion
▸ To understand the latest techniques and technologies in the field
▸ To review the dedicated devices in the pipeline
14:05-14:50
Live demonstration
17:55-18:00
Wrap-up
Chairperson: R. Ng
Co-chairperson: C.K. Naber
Panellists: C. Chan, P. Chandra, Q.H. Do, S. Garg, E. Grube, A.A. Lukito,
S.C. Ng, P.W. Serruys, A.F. Yahya
▸ What we have learned today on PCI in patients with complex bifurcation lesion
- G. Devlin
Live demonstration
Live demonstration from Harapan Kita, Jakarta, Indonesia
Chairperson: H.C. Tan
Panellists: I.H. Chae, J.L Chen, B. Chevalier, A. Colombo, W.Y. Guo, F. Kleber,
T.S. Kler, M. Nakamura, A. Pathan, A. Rahman
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
18
Coronary / Structural / Hypertension scientific programme
Friday 13th
ROOM 2
07:45-08:30
Industry-supported session
Bringing cardiologists to the future
With an unrestricted educational grant from Medtronic
Chairpersons: S.T. Lim, R. Zambahari
Panellists: Y.T. Lim, P. Ong, S. Shetty
Objectives:
▸ To understand how to manage the challenges of the renal denervation
procedure and how to simplify the treatment of complex coronary lesions
▸ To better understand the role of most advanced Medtronic technology to
improve interventional cardiology treatments
▸ Introduction and objectives - S.T. Lim
▸ Renal denervation for resistant hypertension: challenges - S. Shetty
▸ Challenging PCI case at 5 o'clock on Friday: how Resolute Integrity helps to make
the complex simple - P. Ong
▸ Discussion
▸ Take-home message - S.T. Lim
09:00-10:30
“Call for” based session
Clinical case submissions forum II
Chairperson: M. Thomas
Panellists: Y. Koyama, S.C. Ng, A. Rosman, Y. Yuniadi
▸ Difficult retrograde crossing of the aortic valve - a valve in valve CoreValve
case - M. Settergren
▸ Interventional exclusion of a false aneurysm of the ascending aorta with shunt into
right atrium after supracoronary replacement for type A dissection - R. Birkemeyer
▸ Multivessel PCI via CoreValve TAVI graft - R. Linder
▸ Emergency percutaneous balloon aortic valvuloplasty using triple balloon
technique as a bridge to surgical repair due to severe aortic stenosis with
cardiogenic shock - K. Yamazaki
▸ Complex balloon mitral valvuloplasty - J.S.S. Murthy
▸ Dreaded complications during balloon mitral valvotomy - P. Gobu
▸ Device closure of ventricular septal defect complicated with myocardial infarction
three weeks after coronary angioplasty - R. Barik
10:35-12:00
“Call for” based session
Structural heart disease
Chairperson: G. Devlin
Co-chairperson: P. Chiam
Panellists: R. Birkemeyer, Q.T. Nguyen, P. Radke, E. Tay
▸ Introduction and objectives - G. Devlin
▸ Mitral leaflet separation index as indicator of successful balloon mitral valvotomy
- P. Gobu
▸ The contemporary outcome of fifty-two consecutive surgical transcatheter valve
implantations performed in one year - J.L. Soon
▸ The association of body mass index with clinical outcome in patients with severe
aortic stenosis undergoing transcatheter aortic valve implantation - S. Stortecky
▸ Comparison of rotational angiography with multislice computed tomography for
evaluation of the aortic root for transcatheter aortic valve replacement - C. Schultz
▸ Mitral leaflet separation index is an accurate measure for mitral stenosis
- K. A. Alkhashab
▸ Transcatheter aortic valve implantation (TAVI) associated atrioventricular heart
block in self-expandable CoreValve and balloon-expandable Edwards valves
- M. Liang
▸ Is female gender itself a risk factor for development of severe pulmonary
hypertension in secundum atrial septal defect? - S.C. Sinha
▸ Take-home message - P. Chiam
Programme valid as of 28/12/2011. Subject to modification.
19 Final Programme / 12th-14th January, 2012 / Singapore
12:15-13:30
Industry-supported session
How should I treat: the hemodynamically unstable STEMI patient
With an unrestricted educational grant from Maquet Cardiovascular
Chairperson: M. Thomas
Panellists: G. Buchanan, A. Gnanaraj, K.W. Ho, S.T. Lim, Y.K.K Sin, R. Wessely
Objectives:
▸ To learn what is the best treatment strategy for the heamodynamically unstable
STEMI patient
▸ To understand the important role of mechanical support
▸ Introduction and objectives - M. Thomas
Case 1 - Acute myocardial infarction + pre-shock
▸ Case presentation - K.W. Ho
▸ Discussion - R. Wessely
▸ What did I do? - K.W. Ho
Case 2 - Acute myocardial infarction + Ventricular septal defect(s)
▸ Case presentation - G. Buchanan
▸ Discussion - Y.K.K. Sin
▸ What did I do? - G. Buchanan
Case 3 - Acute myocardial infarction + shock
▸ Case presentation - A. Gnanaraj
▸ Discussion - S.T. Lim
▸ What did I do? - A. Gnanaraj
▸ Discussion
14:00-14:55
Left atrial appendage closure in patients with atrial fibrillation
Chairperson: T.H. Koh
Co-chairperson: S. Kar
Panellists: K. Gunasegaran, Y.Y. Lam, M.C. Morice, W.S. Teo, D. Walters
Objectives:
▸ To learn the current indications of LAA closure
▸ To learn about the current techniques and devices
▸ Introduction - T.H. Koh
▸ Overview of LAA closure devices and outcomes - S. Kar
▸ Watchman device implantation techniques - T.H. Koh
▸ AGA device implantation techniques - Y.Y. Lam
▸ Coherex - M.C. Morice
▸ Discussion
▸ Take-home message - S. Kar
15:00-15:55
Percutaneous paravalvular leak closure: a challenge for the Asia-Pacific
interventionalist
Chairperson: E. Eeckhout
Co-chairperson: R.I. Low
Panellists: S. Chandra, K.W. Ho, C.Y. Lee, L.H. Nguyen, Y.K.K. Sin
Objectives:
▸ To understand the current indications
▸ To understand the specific imaging needs
▸ To learn the various approaches and techniques
▸ Indications, limitations and choice of device for percutaneous paravalvular leak
closure - J. Tan
▸ Imaging assessment of percutaneous paravalvular leak - Z.P. Ding
▸ Case presentation: aortic paravalvular leak - R.I. Low
▸ Case presentation: mitral paravalvular leak - E. Eeckhout
▸ Discussion
Coronary / Structural / Hypertension scientific programme
Friday 13th - Room 2
16:00-18:00
“Call for” based session
Complications submissions forum
Chairperson: E. Eeckhout
Co-chairperson: S.T. Lim
Panellists: C.H.P. Ang, A. Erglis, L. Lam, T. Muthusamy , M. Yamin, B. Zhang
▸ The last option.... may something be saved? - M. Cardenas
▸ Blocked right coronary artery flow due to massive air embolisation during
transseptal catheterisation - M. Fujino
▸ PTMC non deflating balloon - a rare complication - V. Bisane
▸ Contralateral reperfusion in right coronary artery to overcome bradyarrhythmia
due to spiral dissection in left circumflex - B. Budiono
▸ How to fix a broken heart - E. Eeckhout
▸ PTCA complication - stent dislodgement in left anterior descending - R. Ghodeswar
▸ Aortic dissection following right coronary artery PCI - V. Gejapati
▸ My worst nightmare: multiple complications during very difficult left main-left
anterior descending PCI - B. Faurie
ROOM 3
07:45-08:30
Industry-supported session
Learn from the experts
With an unrestricted educational grant from Meril Life Sciences
Chairperson: P.W. Serruys
Panellists: T. Santoso, M. Munawar, M.A. Rosli
Objective:
▸ To learn about the evolution of DES and techniques for left main, bifurcation and
coronary chronic total occlusion
▸ Introduction and objectives - P.W. Serruys
▸ A decade of stent design: DES evolution - P.W. Serruys
▸ Techniques for left main - T. Santoso
▸ Treating bifurcation lesions - C.K. Naber
▸ Chronic total occlusions and perforations - A. Mehta
▸ Discussion
08:50-10:20
LTT on transseptal puncture techniques
Facilitators: G. Ducrocq, J. Marco
Panellists: N.Q. Nguyen, M.H. Pham, K.H. Srinivasa
Objective:
▸ To learn the various technical aspects of transseptal puncture techniques
Live in-a-box®
10:35-12:00
Transcatheter mitral interventions
Chairperson: S. Kar
Co-chairperson: K.K. Yeo
Panellists: M.H. Pham, Y.K.K. Sin, R. Zambahari
▸ Introduction - S. Kar
▸ Choosing the right patient with mitral regurgitation for mitral clip interventions importance of echo evaluation - P. Ting
▸ How I do it - mitral clip step-by-step - K.K. Yeo
▸ Technical challenges and complications of mitral clip interventions - S. Kar
▸ Results and updates on mitral clip programme - R.I. Low
▸ Discussion
▸ Dreaded complications during balloon mitral valvotomy - P. Gobu
▸ Discussion
▸ Complex balloon mitral valvuloplasty - J.S.S. Murthy
▸ Discussion
▸ Take-home message - K.K. Yeo
12:15-13:30
Industry-supported session
Titanium-nitride-oxide active stent: combining drug-eluting stent-like clinical
efficacy with bare metal stent safety
With an unrestricted educational grant from Hexacath
Chairpersons: P. Karjalainen, P. Ong
Panellists: M. Angioi, R. Khurana, M. Pietilä
Objectives:
▸ To understand the full potential of Titanium-nitride-oxide coated stents
▸ To share the latest Titan2 clinical data (randomised clinical trial and registry)
▸ To better understand the Titanium-nitride-oxide interest in acute coronary
syndrome patients
▸ Introduction and objectives - P. Ong
▸ Is platelet function testing important before elective PCI ? - R. Khurana
▸ Titan2 Bio Active Stent Singapore experience - P. Ong
▸ One-year clinical outcome of the large scale multicenter prospective registry in
acute myocardial infarction with Titan 2 Bio Active Stent: the CATS-AMI registry
- M. Angioi
▸ The BASE-acute coronary syndrome randomised study and BASE-OCT sub study
at 18 months of follow-up - M. Pietilä
▸ Discussion
▸ Take-home message - P. Karjalainen
14:00-15:55
Imaging session
Update on invasive coronary imaging and functional lesion assessment
(IVUS/OCT/FFR) - Part I
Chairperson: Y. S. Jang
Co-chairperson: A. Low
Panellists: K.T. Chan, Y. Koyama, T.K. Ong, D. Tresukosol
Objectives:
▸ To appreciate the role of invasive imaging and physiology in PCI
▸ To learn image interpretation in complex scenarios
▸ To understand the current limitations of these technologies
▸ Opening remarks - A. Low
▸ The 10 most important new information/developments in IVUS imaging in 2012
- Y. S. Jang
▸ My most educational case on IVUS/OCT/FFR - K.T. Chan
▸ Case submission: Surprising IVUS - O. Gach
▸ My most educational case on IVUS/OCT/FFR - A. Low
▸ Case submission: Repeat myocardial infarction prospected by virtual histology
- K. Hanada
▸ My most memorable complication with the use of IVUS/OCT/FFR - S. Sumitsuji
▸ IVUS/OCT/FFR quiz - Y. S. Jang
16:00-18:00
Imaging session
Update on invasive coronary imaging and functional lesion assessment
(IVUS/OCT/FFR) - Part II
Chairperson: T. Akasaka
Co-chairperson: S. Chia
Panellists: Y.S. Chong, J. Escaned, N. Inoue, P. Karjalainen, S. Lee, P. Wong
Objectives:
▸ To appreciate the role of invasive imaging and physiology in PCI
▸ To learn image interpretation in complex scenarios
▸ To understand the current limitations of these technologies
▸ The 10 most important new developments in coronary anatomy/physiology
assessment (other than IVUS) - T. Akasaka
▸ How to assess arterial healing - S. Lee
▸ Case submission: Late stent thrombosis on top of fractured cypher stent
presenting by STEMI - H. Shaalan
▸ My most educational case on IVUS/OCT/FFR - M. Nakamura
▸ Case submission: Culprit lesion in STEMI, missed by angiography and identified
by OCT - W. Elabbassi
▸ IVUS/OCT/FFR quiz - T. Akasaka, S. Chia
▸ Round table discussion: angiography, IVUS, OCT, FFR...what are the major unmet
imaging needs for practicing interventionist?
▸ Closing remarks - T. Akasaka
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
20
Coronary / Structural / Hypertension scientific programme
Friday 13th
ROOM 201
09:00-09:55
Meet the experts - Stent complications
Chairperson: P. Yan
Co-chairperson: J. Escaned
Panellist: T. Muthusamy
Objectives:
▸ To provide practical answers to situations encountered during daily practice
▸ To improve stenting skill set
16:00-17:45
▸ Overview of stent complications - A. Wong
▸ Stent loss - A. Erglis
▸ Stent thrombosis - P. Radke
▸ Late aneurysmal formation - J. Escaned
▸ Wrap-up - P. Yan
“Call for” based session
PCI and bifurcation stenting
Chairperson: A. Seth
Co-chairperson: G. Ducrocq
Panellist: P. Tedjokusumo
10:00-10:55
Meet the experts - High-risk acute coronary syndrome
Chairperson: M. Choo
Co-chairperson: B. Sitanbaoli
Panellists: R.C.H. Lee, V. Senaratne
Objective:
▸ To learn practical issues in acute coronary syndrome scenarios
▸ Top 10 tips and tricks for primary PCI in STEMI - H. Suryapranata
▸ Acute coronary syndrome PCI in patients with active GI bleeding
▸ STEMI intervention with large thrombus burden - R. Khurana
▸ Acute coronary syndrome in poor LV function - T. Cuisset
▸ Wrap-up - M. Choo
11:00-11:55
Meet the experts - My most educational case
Chairperson: Y.T. Lim
Co-chairperson: D. Dudek
Objective:
▸ To provide practical answers to situations encountered during daily practice
▸ Introduction and objectives - A. Seth
▸ The Tryton side branch stent system in left main disease - B. Scott
▸ The Tryton side branch stent system in left anterior descending - diagonal
bifurcation in-stent restenosis - J. Sonck
▸ Predilatation of side branch during provisional T-stenting for true bifurcation
- T. Kato
▸ Intravascular ultrasound results from the DIVERGE (drug-eluting stent
intervention for treating side branches effectively) study - S. Verheye
▸ Influence of technique and anatomy on strut apposition in provisional stenting:
insights from micro-computed tomography and optical coherence tomography
- N. Foin
▸ Two-year clinical outcome with a new generation drug-eluting stent: a challenge in
bifurcation treatment - B. Chevalier
▸ Repeated drug-eluting stent implantation for drug-eluting stent restenosis: first or
second generation drug-eluting stent - K. Yamashita
▸ Overdilation of paclitaxel-eluting stent not associated with higher restenosis rates
- K. Yamashita
▸ Two-year results: off label use of drug-eluting stent with biodegradable polymer
- T. Santoso
▸ Take-home message - G. Ducrocq
ROOM 208
▸ Management of no reflow in PCI - O. Muller
▸ Left main PCI in cardiogenic shock - D. Dudek
▸ Trapped rotablator burr - S. Chia
▸ Case presentation
▸ Wrap-up - Y.T. Lim
15:30-17:00
How to prepare and deliver an efficient PowerPoint presentation
A joint session EAPCI-PCR Educative Solutions
Facilitator: J. Marco
Discussants: T. Cuisset, G. Ducrocq, M.C. Morice, M. Thomas
Objectives:
▸ To understand the strengths and weaknesses of PowerPoint as a support for
a lecture or a teaching session
▸ To state the importance of a step-by-step process in 10 points to prepare
a PowerPoint presentation
▸ To understand how to deliver a lecture based on a PowerPoint presentation
12:15-13:10
How to write a paper
With the collaboration of EuroIntervention
Chairpersons: E. Eeckhout, P.W. Serruys
Panellist: J. Escaned
Objective:
▸ To learn the tips and tricks for a successful publication
▸ Introduction - P.W. Serruys
▸ Common downfalls for medical papers - S. Garg
▸ Statistics tips and tricks - C. K. Naber
▸ How to review a medical paper - J. Escaned
▸ EuroIntervention Journal - P. Cummins
▸ PCR-EAPCI textbook - E. Eeckhout
▸ Take-home message - E. Eeckhout
13:55-15:55
▸ Thrombus: a moving target - C. Yeo
▸ Newly developed giant right ventricular wall hematoma just after simple
transradial coronary intervention - C. Kook-Jin
▸ Catheter tip embolisation into critical LMCA, emergency LMCA PCI - K. Vasudevan
▸ Stenting after retrograde recanalisation of Ao-right coronary artery bypass and left
anterior descending chronic total occlusion - A. Osiev
▸ Large coronary aneurysm after coronary perforation in a rotational atherectomy
procedure - E. Benit
▸ Primary PCI of an anomalous right coronary artery arising from the left coronary
cusp using a left Judkins guiding catheter - V. Gejapati
▸ Complication of PCI (abscess) - A. Noeman
▸ Interactive session illustrated with concrete examples from PCRonline
Saturday 14th
MAIN ARENA
“Call for” based session
Clinical case submissions forum III
Chairperson: P. Wong
Co-chairperson: O. Muller
Panellists: S.W. Kyaw, S. Rifqi
▸ Complication in management of acute MI in treated by emergency CABG and
left ventricular assist device by extracorporeal membrane oxygenation
- M. Bedossa
▸ PCI over a torturous, calcified and totally occluded right coronary artery - F.Y. Kuo
Programme valid as of 28/12/2011. Subject to modification.
21 Final Programme / 12th-14th January, 2012 / Singapore
08:30-12:50
MORNING TOPIC
Non-coronary transcatheter interventions in 2012
Objectives:
▸ To learn about patient selection, techniques and remaining
issues for TAVI
▸ To learn about indications, techniques and remaining issues for
ASD closure
▸ To understand the techniques and the potential of renal
denervation for the treatment of resistant hypertension
Coronary / Structural / Hypertension scientific programme
Saturday 14th - Main Arena
08:30-09:20
Live demonstration
12:35-12:50
Live demonstration from the National Heart Centre Singapore
Chairperson: S.T. Lim
Co-chairperson: M. Thomas
Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low,
G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay
My vision of the future of non-coronary transcatheter interventions
Chairperson: A. Colombo
Co-chairperson: P. Wong
Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, O. Muller, L.H. Nguyen,
A. Pathan
▸ Introduction - S.T. Lim
▸ My vision of the future of non-coronary transcatheter interventions
- P.W. Serruys
08:35-09:20 Live demonstration from the National Heart Centre Singapore
09:20-09:40
Mini debate
Perspectives on TAVI
Chairperson: S.T. Lim
Co-chairperson: M. Thomas
Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low,
G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay
▸ Setting the stage - M. Thomas
▸ My practice - M.A. Rosli
▸ My practice - M. Thomas
▸ My practice - I. Meredith
▸ What we have learned - S.T. Lim
09:40-10:20
How should I treat? session
How should I treat? - TAVI
Chairperson: S.T. Lim
Co-chairperson: M. Thomas
Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low,
G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay
▸ Case presentation - C.K. Naber
▸ How would I treat? - W. Buddhari
▸ How would I treat? - G. Devlin
▸ How did I treat? - C.K. Naber
▸ Discussion
▸ Consensus - M. Thomas
My most educational case: learn from the experts
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: J. Fajadet, R. Gao, S.T. Lim, J. Marco, M.C. Morice, C.K. Naber,
M.A. Rosli, P.W. Serruys, A. Wong
▸ A complete patient care - M.C. Morice
▸ Buried under the rock - A. Seth
▸ Case presentation - J. Fajadet
▸ Case presentation - S. Nakamura
▸ Management of a coronary perforation with tamponade - A. Colombo
▸ How to fix this leak - E. Eeckhout
14:25-14:55
Presentation of 2012 awards and closing ceremony
Chairperson: T.H. Koh
Co-chairperson: E. Eeckhout
Panellists: J. Fajadet, R. Gao, S.T. Lim, J. Marco, M.C. Morice, C.K. Naber,
M.A. Rosli, P.W. Serruys, A. Wong
▸ AsiaPCR/SingLIVE 2012 best abstracts - A. Wong
▸ AsiaPCR/SingLIVE 2012 best clinical case - S.T. Lim
▸ AsiaPCR/SingLIVE 2012 best How should I treat? - M.C. Morice
▸ AsiaPCR/SingLIVE in the future - J. Marco
▸ Highlights and closing remarks - T.H. Koh
10:20-11:05
Live demonstration
Live demonstration from the National Heart Centre Singapore
Chairperson: S.T. Lim
Co-chairperson: M. Thomas
Panellists: W. Buddhari, Y.L. Chua, G. Devlin, J. Fajadet, A. Low,
G. Manoharan, I. Meredith, C.K. Naber, M.A. Rosli, E. Tay
11:10-11:50
12:55-14:25
How should I treat? session
How should I treat? - LAA closure
Chairperson: A. Colombo
Co-chairperson: P. Wong
Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, Y.Y. Lam, O. Muller,
L.H. Nguyen, A. Pathan, R. Tangco
▸ Case presentation - T.H. Koh
▸ How would I treat? - R. Tangco
▸ How would I treat? - Y.Y. Lam
▸ How did I treat? - T.H. Koh
▸ Discussion
▸ Consensus - A. Colombo
11:50-12:35
ROOM 2
08:30-11:30
Sharing experience on coronary chronic total occlusion with experts
Chairperson: A. Wong
Co-chairperson: N. Inoue
Panellists: J. Escaned, Y.L. Han, T.H.S. Lo, F. Mauri, T. Muramatsu, S. Nakamura
Objectives:
▸ To learn and discuss pro and contra of the various techniques for complex
coronary chronic total occlusion
▸ To explain the selection criteria and use of dedicated wires and other specific
devices
08:30-09:20 Live demonstration from the National Heart Centre Singapore
▸ Current state of art in coronary chronic total occlusion approaches - T. Muramatsu
09:30-10:20 Live in-a-box®
▸ Update on reverse-cart techniques - N. Inoue
10:30-11:20 Live demonstration from the National Heart Centre Singapore
Live demonstration
Live demonstration from the National Heart Centre Singapore
Chairperson: A. Colombo
Co-chairperson: P. Wong
Panellists: S. Chandra, A. Chopra, S. Kar, T.H. Koh, Y.Y. Lam, O. Muller,
L.H. Nguyen, A. Pathan, R. Tangco
▸ Use of epicardial collateral channels - E. Tsuchikane
11:35-13:30
Interactive case-based review discussion
Facilitator: J. Marco
Panellists: F. Malik, A. Mehta, C.K. Naber, A. Rahman
11:50-12:20 Live demonstration from the National Heart Centre Singapore
▸ Indications - E. Eeckhout
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
22
Special programme
Nurses, technicians and radiographers forum
The Nurses, technicians
and radiographers Forum
at AsiaPCR/SingLIVE this
year is dedicated to the
critical review of important
practical issues in percutaneous coronary and structural interventions. The forum is specifically designed to meet the
needs of experienced nurses, technicians and radiographers working in the field of interventional cardiology, taking into account
local practices and constraints.
The first part of this forum will include an interactive LTT session,
with a special focus on “Scrubbing in for bifurcation PCI”. This
session is developed to help our participants understand the indications for the procedure, all the elements of the decision-making
process, technical aspects of device preparation as well as how to
anticipate potential complications, using a recorded case to
illustrate each step of the process.
NEW IN 2012
The second half of the forum aimes to critically appraise current
evidence for Cathlab management of STEMI and cardiogenic
shock, as well as practical issues in using pressure wire in coronary
intervention, chronic total occlusion interventions and obtaining
optimal cineangiographic images. With the emergence of TAVI
as an alternative to high-risk surgical aortic valve replacement,
our speakers will also guide our audience through a systematic
approach to TAVI and review the nursing management of potential
acute complications.
Through this interactive forum, the participants will be able to
explore and understand current management of these important
conditions and have the opportunity to challenge current practice
in order to develop a clear consensus on how to deliver the best
possible outcome in their own practice.
Stanley Chia
Veronica Kwok
Programme Coordinators
THURSDAY 12th
ROOM 201
13:45-15:15
15:30-18:00
Nurses, technicians and radiographers forum - Part 1
Scrubbing in for bifurcation PCI
Facilitators: S. Buendia, S. Chia, V. Kwok
Panellists: G. Ducrocq, R.B.A. Ghani, W.Y. Guo
Nurses, technicians and radiographers forum - Part 2
Chairperson: S. Chia
Co-chairperson: V. Kwok
Panellists: S. Buendia, R.B.A. Ghani
Objectives:
▸ To learn the technical aspects of the device preparations
▸ To anticipate technical issues during PCI
▸ To learn how to manage complications
Objectives:
▸ To learn the technical aspects of the device preparations
▸ To anticipate technical issues during PCI
▸ To learn how to manage complications
Live in-a-box®
▸ Introduction and objectives - S. Chia
▸ Coordinated approach in the treatment of STEMI - J.J. Cheng
▸ Scrubbing-in for coronary chronic total occlusion intervention - R.B.A. Ghani
▸ Management of cardiogenic shock in the cathlab - S. Chia
▸ Practical issues in the setup and use of pressure wire in PCI - S. Buendia
▸ How to achieve optimal cineangiographic images in coronary interventions
▸ Step-by-step approach to TAVI - M. Thomas
▸ Nursing management of TAVI acute complications and co-morbid conditions
- V. Kwok
▸ Question and answers
▸ Take-home message - V. Kwok
Programme valid as of 28/12/2011. Subject to modification.
23 Final Programme / 12th-14th January, 2012 / Singapore
Special programme
Imaging sessions
Cardiac imaging continues to evolve and has
an increasingly crucial role in the performance
of complex coronary and structural heart
interventions.
Our international speakers this year include Professor Sujith
Seneviratne of Monash Heart Southern Health, who is both
an interventional cardiologist and a leading expert on cardiac
computed tomography.
To highlight and improve our understanding
of how to best make use of imaging in a wide
range of settings, this year’s computed tomography and multimodality imaging programme will focus on
several key themes. These include how the latest techniques in
imaging can potentially help guide coronary interventions, the
controversial issue of viability imaging prior to revascularisation,
the pivotal contribution of imaging in valvular interventions, and
the emerging role of imaging in the emergency room.
Other experts will share their experience on the potential of cardiac
MRI, how echocardiography is useful in percutaneous valve
implantation and advances in cardiac computed tomography.
If you have an interest in cardiac imaging, or wish to better
understand how imaging can contribute to intervention, this
programme is for you!
Terrance Chua
Course Co-Director
FRIDAY 13th
ROOM 209
08:45-11:00
13:35-15:30
Guiding intervention with imaging: which test?
Chairpersons: F.K. Cheah, K-H. Sim
Panellists: Y.J.F. Keng, S.Y. Tan
Multimodality imaging for valvular interventions
Chairpersons: P.P. Goh, M.A. Rosli
Panellists: P. Chiam, S.H. Ewe
Objectives:
▸ To learn the strengths and limitations of each imaging method
▸ To understand how to better choose the right test for each clinical situation
Objectives:
▸ To learn how to use imaging for valvular intervention
▸ To understand the strengths and limitations of each technique
▸ Opening remarks - S.J.T. Chua
▸ Keynote lecture: the role of cardiac computed tomography in interventional
cardiology - S. Seneviratne
▸ Case-based discussion: cardiac magnetic resonance imaging - the one test
that does it all? - A.S. Low
▸ Case-based discussion: is there still a role for nuclear cardiology in 2012?
Y.J.F. Keng
▸ Case-based discussion: stress perfusion imaging using cardiac computed
tomography - K.T. Ho
▸ Questions and answers
▸ The role of computed tomography in valvular interventions - S.Y. Tan
▸ The role of echo in valvular interventions - Z.P. Ding
▸ Case-based discussion: aortic valve disease - P. Chiam
▸ Case-based discussion: mitral valve disease - K.K. Yeo
▸ Questions and answers
11:00-12:15
Objective:
▸ To understand the potential role and limitations of imaging in the emergency
department using computed tomography and/or nuclear imaging
Viability imaging: time for a re-think?
Chairpersons: S.J.T. Chua, H.Y. Ong
Objectives:
▸ To have a better understanding of the latest trial data on viability testing
▸ To learn how it can help us to select patients for revascularisation
▸ Approach to the patient with impaired left ventricular function - K.K. Poh
▸ Case-based discussion: viability imaging after STICH - R.S. Tan
▸ Case-based discussion: a surgeon's perspective on viability - Y.L. Chua
▸ Questions and answers
15:30-17:00
Imaging in the emergency department
Chairpersons: S.Y. Tan, Q.W. Yong
Panellists: YS.J.T. Chua, .J.F. Keng
▸ Keynote lecture: computed tomography for acute chest pain - ready for prime
time? - S. Seneviratne
▸ Case-based discussion: chest pain in the emergency room - the nuclear option
S.J.T. Chua
▸ Questions and answers
▸ Closing remarks - S.J.T. Chua
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
24
Special programme
Endovascular sessions
Endovascular interventions continue to grow
in range and complexity. The programme for
2012 will be held on 14th January 2012 to
enable interested participants to be more
focused.
The faculty featured will be experts from
around the world and from South East Asia.
Among the featured topics are lower limb interventions, the treatment of aortic aneurysms and new techniques like renal denervation.
These will be workshop style sessions to enable maximum interaction
between faculty and participants.
The talks will be complemented by case-based learning, which are
presented and discussed by a panel of experts. The ever popular
‘Complications’ session will be a highlight of the programme,
where experts share their nightmare cases in a learning environment.
The programme will be of interest to all specialists practicing in the
vascular arena, including vascular specialists, radiologists, surgeons
and cardiologists, and doctors-in-training in these fields.
Bien-Soo Tan
Course Co-Director
SATURDAY 14th
07:30-08:20
ROOM 209
"Call for" based session
Endovascular Case Forum
Chairperson: B.S. Tan
Co-chairperson: S.T. Lim
Panellists: A. Gogna, F. Irani
▸ Introduction - S.T. Lim
▸ Endovascular salvage intervention for 10 year aortoiliac occlusion - H.L. Huang
▸ Angiojet thrombectomy in the acute subclavian artery thrombosis patient - T.Y. Wu
▸ Post renal transplant - graft renal artery stenting in a complex anatomy
S.S.R. Parupati
▸ Successful endovascular treatment of spontaneous abdominal aortic
dissection in Takayasu's arteritis - K. Narayanan
▸ Immediate normalisation of blood pressure following intervention in functional
total occlusion of unilateral renal artery with an atrophic kidney - P. Singh
▸ Take-home message - B.S. Tan
08:30-10:30
New horizons in lower limb interventions
Chairperson: K.H. Tay
Panellists: M. Chen, E. Liu
Objectives:
▸ To update the guidelines for critical limb ischaemia management
▸ To demonstrate a step-by-step approach for superficial femoral artery and
below the knee interventions
▸ To share the latest techniques for superficial femoral artery and below the knee
interventions
▸ Critical limb ischemia - update on management guidelines - S.P. Chng
▸ Superficial femoral artery interventions - an update - M. Spanger
▸ Superficial femoral artery intervention SAFARI technique - recorded case
T.N. Yeow
▸ Is there a role for drug-eluting stent and drug-eluting balloon in the lower limb
interventions? - D. Rajan
▸ Below the knee intervention - recorded case - M. Burgmans
10:30-12:30
Aortic aneurysms - evolving endovascular techniques
Chairperson: Y.K.K. Sin
Panellists: P. Robless, D. Wong
Objectives:
▸ To demonstrate the latest techniques in endovascular and hybrid management
of thoracic and abdominal aortic aneurysms
▸ To demonstrate a step-by-step endovascular approach to aortic aneurysms
▸ Branched endografts for thoracic and abdominal aneurysms - D. Rajan
▸ Abdominal aortic aneurysm - recorded case - F. Irani
▸ The chimney technique - M. Taneja
▸ TA - recorded case - V. Chao
▸ Hybrid procedures - K.H. Tay
12:30-14:00
How should I treat? session
How should I treat?
Chairperson: M. Taneja
Panellists: Y.T.P. Goh, Z. Kyaw
Objective:
▸ To learn advanced endovascular techniques from various experts through
interactive case based discussions
▸ Case presentation - M. Spanger
▸ How would I treat? - D. Rajan
▸ How did I treat? - M. Spanger
▸ Case presentation - M. Chen
▸ How would I treat? - D. Wong
▸ How did I treat? - M. Chen
▸ Case presentation - K.S. Ng
▸ How would I treat? - D-D. Do
▸ How did I treat? - K.S. Ng
14:10-15:30
Renal interventions: the end of renal artery revascularisation?
Chairperson: T.N. Lau
Panellists: G.C. Chua, D. Rajan, J. Tan
Objectives:
▸ To discuss the current status of renal artery revascularisation
▸ To discuss new techniques in hypertension management
▸ To demonstrate the technique of percutaneous denervation
▸ Renal artery angioplasty and stenting - is it obsolete? - S. Punamiya
▸ New techniques for hypertension management - S. Shetty
▸ Renal denervation - recorded case - S. Shetty
15:30-17:00
Clinical case session
My worst nightmare: complications session
Chairperson: B.S. Tan
Panellists: S. Kum, P. Sidipratomo
Objective:
▸ To learn how to avoid and manage complications through a panel of experts
sharing their cases and lessons learned
▸ Case presentation - M. Azeemuddin
▸ Case presentation - U. Pua
▸ Case presentation - K.K. Yeo
▸ Case presentation - A. Tang
▸ Case presentation - D-D. Do
▸ Discussion
▸ Take-home message - B.S. Tan
Programme valid as of 28/12/2011. Subject to modification.
25 Final Programme / 12th-14th January, 2012 / Singapore
Training programme
Thursday 12th
07:30
08:00
08:30
09:00
09:30
10:00
ABBOTT VASCULAR
Room 203
10:30
11:00 11:30
12:00
13:30
14:00
14:30
15:00
15:30
16:00 16:30
17:00
Virtual simulator, Endovascular
Optical coherence tomography
Fractional flow reserve
CORDIS
Room 205
Vascular closure
device
Vascular closure
device
BOSTON SCIENTIFIC
Room 206
Vascular closure
device
LAA closure technology
Rotablator atherectomy system
MAQUET
CARDIOVASCULAR
Room 207
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
07:30
08:30
09:30
10:30
11:30
Cardiogenic
shock high-risk
PCI
12:30
ABBOTT VASCULAR
Room 203
13:30
14:30
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
15:30
16:30
MitraClip therapy, Endovascular
ST JUDE MEDICAL
Room 204
Fractional flow reserve
Optical coherence tomography
CORDIS
Room 205
Vascular closure
device
Vascular closure
device
BOSTON SCIENTIFIC
Room 206
Vascular closure
device
LAA closure technology
Rotablator atherectomy system
MAQUET
CARDIOVASCULAR
Room 207
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
Saturday 14th
07:30
08:00
08:30
09:00
09:30
ABBOTT VASCULAR
Room 203
10:00
10:30
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
11:00 11:30
12:00
Cardiogenic
shock high-risk
PCI
12:30
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
13:00
Coronary chronic total occlusion guide
wires tip sharing, Virtual simulator
CORDIS
Room 205
Vascular closure
device
MAQUET
CARDIOVASCULAR
Room 207
Intra-aortic
balloon pump
& intra-aortic
balloon catheter
Thursday 12th
Room 203
13:00
Side branch access stent, MitraClip therapy, Coronary chronic total occlusion guide wires tip sharing,
ST JUDE MEDICAL
Room 204
Friday 13th
12:30
Vascular closure
device
Cardiogenic
shock high-risk
PCI
09:30-12:00
14:00-17:00
ABBOTT VASCULAR
09:30-12:00
14:00-17:00
Training village
MitraClip therapy
Trainer: P. Wray
Objective:
▸ To increase current understanding of the MitraClip therapy and procedure
09:30-12:00
14:00-17:00
Training village
Coronary chronic total occlusion guide wires tip sharing
Trainer: I. Haruna
Objective:
▸ To learn basic technique and tips and tricks of guide wires shaping for coronary
chronic total occlusions
Training village
Virtual simulator
Trainer: S. Yen
Objective:
▸ To learn basic PCI and EVT procedure and techniques
09:30-12:00
14:00-17:00
Training village
Endovascular
Trainer: R. Kwan
Objectives:
▸ To learn the basic technique on large hole wound closure
▸ To understand the building blocks of peripheral guide wires and balloons
10:30-12:00
15:00-16:30
Training village
Side branch access stent
Trainer: F. Guenther
Objective:
▸ To understand the fundamental characteristic of side branch access stent
technology
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
26
Training programme
Programme valid as of 28/12/2011. Subject to modification.
Thursday 12th
Room 204
ST JUDE MEDICAL
09:00-17:00
Training village
Hands-on workshop
Objectives:
▸ To emphasize on the PCI optimisation with optical coherence tomography and
fractional flow reserve technology
▸ To provide an advanced hands-on training designed to demonstrate AngioSeal deployment
11:00-12:00
Training village
Optical coherence tomography
Trainer: S. Chia
Objectives:
▸ To learn how to prepare the optical coherence tomography console and catheter
for image acquisition.
▸ To learn basic optical coherence tomography image intepretation
▸ To recognise common image artifacts
▸ To understand the limitations of optical coherence tomography
16:00-17:00
Training village
Fractional flow reserve
Trainer: R. Khurana
Objectives:
▸ Fractional flow reserve versus IVUS
▸ To learn how to prepare the fractional flow reserve console and pressure wire
Room 205
CORDIS CORPORATION
A Johnson & Johnson company
09:30-10:30
11:30-12:30
14:00-15:00
Training village
09:00-17:00
BOSTON SCIENTIFIC
Training village
WATCHMAN LAA closure technology
Trainer: J. Mahdi
Training village
WATCHMAN LAA closure technology
Trainer: S. Kar
Objectives:
▸ To introduce the concept/clinical need for LAA closure
▸ To provide an overview of the Watchman LAA Closure procedure
▸ To review and discuss key clinical data on the Watchman device
09:00-17:00
11:30-12:30
15:00-16:00
Training village
CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic
Balloon Catheter
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To provide an insight into the newest technology and the benefits for both user
and patient
▸ To understand the positive effects of the bigger sized balloon
▸ To have a better understanding of the significance of speed in challenging patients
13:30-14:30
Training village
Therapy update: cardiogenic shock; high risk PCI
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To know how to handle cardiogenic shock during primary PCI
▸ To understand the role of hemodynamic support during high-risk PCI
▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks
Friday 13th
Room 203
09:30-12:00
14:00-17:00
ABBOTT VASCULAR
Training village
MitraClip therapy
Trainer: P. Wray
09:30-12:00
14:00-17:00
Training village
Rotablator atherectomy system
Trainer: P. Becker
Objectives:
▸ To demonstrate the use of the Rotablator system for treatment of calcified
lesions, with a complete family of products
▸ To provide an overview of the importance of pre-treatment of calcified lesion
with rotational atherectomy
27 Final Programme / 12th-14th January, 2012 / Singapore
Training village
Endovascular
Trainer: R. Kwan
Objectives:
▸ To learn the basic technique on large hole wound closure
▸ To understand the building blocks of peripheral guide wires and balloons
Room 204
09:00-17:00
Objectives:
▸ To introduce the concept/clinical need for LAA closure
▸ To provide an overview of the Watchman LAA Closure procedure
▸ To review and discuss key clinical data on the Watchman device
12:00-14:00
MAQUET CARDIOVASCULAR
Objective:
▸ To increase current understanding of the MitraClip therapy and procedure
Cordis Exoseal vascular closure device hands-on workshop
Trainers: A. Tan, B.Y. Yeoh
Objectives:
▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a
safe and effective tool
▸ To have hands-on experience with this new device
Room 206
Room 207
ST JUDE MEDICAL
Training village
Hands-on workshop
Objectives:
▸ To emphasize on the PCI optimisation with optical coherence tomography and
fractional flow reserve technology
▸ To provide an advanced hands-on training designed to demonstrate AngioSeal
deployment
09:30-10:30
Training village
Fractional flow reserve
Trainer: J. Tan
Objectives:
▸ To understand physiological versus morphology approach
▸ To undesrtand the importance of Hyperemia
▸ To learn the practical pitfalls in the use of fractional flow reserve
11:00-12:00
Training village
Optical coherence tomography
Trainer: Dr Zhang
Objective:
▸ To use optical coherence tomography to give the physician insight for enhanced
revascularisation decision making
Training programme
Friday 13th
Room 205
CORDIS CORPORATION
A Johnson & Johnson company
09:30-10:30
11:30-12:30
14:00-15:00
Training village
Room 203
ABBOTT VASCULAR
09:30-12:00
Cordis Exoseal vascular closure device hands-on workshop
Trainers: A. Tan, B.Y. Yeoh
Objectives:
▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a
safe and effective tool
▸ To have hands-on experience with this new device
Room 206
BOSTON SCIENTIFIC
09:00-17:00
Training village
WATCHMAN LAA closure technology
Trainer: J. Mahdi
Objectives:
▸ To introduce the concept/clinical need for LAA closure
▸ To provide an overview of the Watchman LAA Closure procedure
▸ To review and discuss key clinical data on the Watchman device
09:00-17:00
Training village
Rotablator atherectomy system
Trainer: P. Becker
Objectives:
▸ To demonstrate the use of the Rotablator system for treatment of calcified
lesions, with a complete family of products
▸ To provide an overview of the importance of pre-treatment of calcified lesion
with rotational atherectomy
12:00-14:00
Training village
WATCHMAN LAA closure technology
Trainer: S. Kar
Objectives:
▸ To introduce the concept/clinical need for LAA closure
▸ To provide an overview of the Watchman LAA Closure procedure
▸ To review and discuss key clinical data on the Watchman device
Room 207
Saturday 14th
MAQUET CARDIOVASCULAR
10:00-11:00
11:30-12:30
15:00-16:00
Training village
CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic
Balloon Catheter
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To provide an insight into the newest technology and the benefits for both user
and patient
▸ To understand the positive effects of the bigger sized balloon
▸ To have a better understanding of the significance of speed in challenging patients
13:30-14:30
Training village
Coronary chronic total occlusion guide wires tip sharing
Trainer: I. Haruna
Objective:
▸ To learn basic technique and tips and tricks of guide wires shaping for coronary
chronic total occlusions
09:30-12:00
Training village
Virtual simulator
Trainer: S. Yen
Objective:
▸ To learn basic PCI and EVT procedure and techniques
Room 205
09:30-10:30
11:30-12:30
CORDIS CORPORATION
A Johnson & Johnson company
Training village
Cordis Exoseal vascular closure device hands-on workshop
Trainers: A. Tan, B.Y. Yeoh
Objectives:
▸ To get a thorough overview of the new Cordis Exoseal vascular closure device, a
safe and effective tool
▸ To have hands-on experience with this new device
Room 207
10:00-11:00
MAQUET CARDIOVASCULAR
Training village
CARDIOSAVE - Intra-Aortic Balloon Pump; SENSATION PLUS - Intra-Aortic
Balloon Catheter
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To provide an insight into the newest technology and the benefits for both user
and patient
▸ To understand the positive effects of the bigger sized balloon
▸ To have a better understanding of the significance of speed in challenging patients
11:30-12:30
Training village
Therapy update: cardiogenic shock; high risk PCI
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To know how to handle cardiogenic shock during primary PCI
▸ To understand the role of hemodynamic support during high-risk PCI
▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks
Training village
Therapy update: cardiogenic shock; high risk PCI
Trainers: A. Neitzert, C. Surmann
Objectives:
▸ To know how to handle cardiogenic shock during primary PCI
▸ To understand the role of hemodynamic support during high-risk PCI
▸ To reemphasise that the benefits of counterpulsation therapy outweigh the risks
Programme valid as of 28/12/2011. Subject to modification.
Final Programme / 12th-14th January, 2012 / Singapore
28
News from the Chien Foundation
Third annual AsiaPCR/SingLIVE
Chien Foundation Lectureship
awarded to Dr. Richard Ng
The presentation of this prestigious
award will take place this Friday January 13th in the Main Arena at noon.
The Chien Foundation Lectureship
award was introduced in 2008 and
seeks to honour and show appreciation to outstanding teachers and
promoters in education and research
in interventional cardiology in AsiaPacific countries. This year’s awardee
Dr Richard Ng studied at our University of Singapore Medical College and
also briefly at the University of
Dundee DRI (Dundee Royal Infirmary)
as an exchange scholarship student.
He graduated in 1970 and three
years later, in 1973, was awarded the
Master of Medicine (Internal Medicine) in Singapore, MRACP in Australia
and MRCP in London. He proceeded
on a Fellowship to London National
Heart Hospital in 1975 and was a
staff Registrar for three years.
He worked with many well-known
cardiologists and cardiac surgeons
but one of his distinctions was to be
Anthony Rickards’ first Registrar. In
1997, he furthered his cardiology
fellowship at Cedars-Sinai Medical
Centre with Dr Jeremy Swan.
He returned to Singapore in 1978 as
a Senior Lecturer in Medicine at the
University of Singapore.
By 1980, Dr Ng left at the early age
of 35 years to work in newly established private practice, Mount Elizabeth
Medical Centre; continuing also as a
Visiting Consultant to the Ministry of
Health. By his own initiative and
expense, Dr Ng went to study with
Richard Myler and Simon Stertzer at
the San Francisco Heart Institute for
a short fellowship in 1984, learning
the very beginnings of percutaneous
transluminal coronary angioplasty
[PTCA].
Following this fellowship, he brought
home equipment to carry out the
first three successful balloon PTCA at
Mount Elizabeth Hospital. This was
presented in the Academy of Medicine,
Singapore and, in 1986, he presented
his 19 cases of balloon PTCA to the
Academy of Medicine Annals. Dr Ng
truly is the father of PTCA in Singapore, and probably Asia, as all these
cases were carried out without any
foreign expertise in his catheter lab at
Mount Elizabeth. In 1978, he organised
the first live PTCA course in Singapore
at Mount Elizabeth Hospital with
guest experts from the USA and
Europe and concluding successfully
with 15 patients.
He has been a very active member of
the cardiology community, not just in
Singapore, but also on the international circuit. His humble and dedicated
nature has earned him an extensive
global network of friends and associates, besides a faithful client base.
Dr Ng is one of the early pioneers
of Singapore’s participation and
involvement in many professional
and international conferences and
cardiac societies. Through his vision
to bring unity and recognition to the
different cardiac societies in the
region, he also organised many local,
regional and international cardiology
associations and meetings.
Designed to reduce the learning
curve of the heart team
2012 EDITION
30th September - 2nd October
He has been elected President of the
Singapore Cardiac Society for nine
separate terms.
Dr Ng has also been a very active
President and Advisor in the Asian
Federation of Cardiology and has
done charity work in cardiology in
China, Myanmar, Vietnam, Indonesia,
Laos and East Malaysia.
He is the Founding Director of the
ASEAN College of Cardiology and
the founding president of the Asian
Pacific Society of Interventional Cardiology that was established in 1990.
He is an active board member for
many charitable foundations and
organisations.
Last but not least, Dr Ng has played
a key and vital role in the formation
and vitality of Chien Foundation.
His ideas and contributions have
benefitted many interventionists in
the Asia-Pacific region in the area of
education, training and research.
His modest and gentle manners belie
a dynamic character who places importance on helping others, especially
the younger and weaker members of
the community, to assist them to
achieve their best. A man who places
great value on integrity and generosity,
in his own quiet and unassuming
way, he has been an ambassador in
the world of interventional cardiology,
bringing and bridging people and
ideas together for the good and
advancement of healthcare for Singapore, the Asia-Pacific region and
beyond.
Join the Chien Foundation
Lectureship
Friday 13th - Main Arena
12:00 - 12:10
29 Final Programme / 12th-14th January, 2012 / Singapore
www.pcrlondonvalves.com
EuroIntervention Journal
EuroIntervention at AsiaPCR/SingLIVE 2012
Patrick W. Serruys, Editor-in-Chief, EuroIntervention
We can say that the world we live
in is growing smaller each day,
and that may be true in our ability
to communicate, to travel, to exchange ideas and experience. But
it is our differences, our unique
and individual ways of looking
and experiencing that world, that
offer us the most tangible opportunities to improve ourselves and
our practice.
My years of experience dealing with
my Asian colleagues have taught me
that, and I owe them easily as much
as I have offered to them. For these
reasons I see meetings such as
AsiaPCR/ SingLIVE as essential to the
evolution of our work, and I look forward, as I have for over thirty years,
to this valuable exchange.
Although this is the third time I will
be present at AsiaPCR/SingLIVE 2012,
it will be the first time that EuroIntervention will have a prominent role.
I will be chairing, with Eric Eeckhout,
in my capacity as Editor-in-Chief of
the journal the "Tips & tricks for a
successful publication" session.
This session has become, since its
inception at EuroPCR, a resounding
success. At this year’s session in Paris,
we noticed that a significant group of
attendees came from the Middle East
and the Pacific Rim, with our friends
and colleagues from far afield
participating in lively discussions with
the experts. An invitation was quickly
forthcoming from the AsiaPCR/
SingLIVE 2012 Directors to launch the
session in Singapore,which we gladly
accepted.
The session will include helpful suggestions in the art of writing, avoiding the common pitfalls, how to
review a medical paper and also
provide tips with statistics. The session will provide a unique platform
for discussions, for you to seek answers or advice of the invited experts
to become a successful writer or reviewer. Our last issue of Eurointervention, December 2011, illustrates this
growing success with some interesting papers published from the Pacific
Rim.
EuroIntervention is but one arm of
PCR Publishing and during the session, we will present also a sneak preview of PCR-EAPCI textbook which
will be launched at EuroPCR 2012.
Together with the Editors of the
book, let me assure that this book, although a mammoth undertaking
with over 90 chapters encompassing
the whole scope of our interventional
field, is a fantastic educative endeavour of which we all are very proud of.
As many iPad users will know (I too am
one of the 25 million - June 2011), that
EuroIntervention is freely available as
an app at the iTunes store and 2012
will also see PCR Publishing present
the OCT interactive atlas, exclusively
published on the iPad.
Finally, on behalf of the Editors of
EuroIntervention and our presenters,
I cordially invite you to the “Tips &
tricks for a successful publication”
session on 13/01/201 in room 201 at
12:15-13:10. We look forward not
only in the coming months, but also
in the long term, to submissions to
EuroIntervention.
How to write a paper
Friday 13th - Room 201
12:15-13:10
SEE YOU
NEXT YEAR
www.asiapcr.com
Final Programme / 12th-14th January, 2012 / Singapore
30
Interview
Interview with Jun-Jack Cheng
Programme Committee Member, Director of the Medical Department of Shin Kong Hospital,
Secretary General of Taiwan Society of Cardiology and Course Director of Taiwan Transcatheter Therapy (TTT)
Please tell us about yourself?
I am Doctor Jun-Jack Cheng, the Director of the Medical Department
of Shin Kong Hospital in Taipei, the Secretary General of the Taiwan
Society of Cardiology, and also the Course Director of Taiwan
Transcatheter Therapy (TTT 2011-2014).
When you are committed to something, especially in the medical field,
there is a lot to contribute. Time and money are always a problem,
but by making an effort, I have been able to gratify my desire to
contribute.
Cooperating with different societies, it is my goal not only to bolster
the newest intervention techniques, but also to learn fresh ideas from
different doctors on how to approach my goals.
How has the current evidence influenced your approach in
patients requiring left main intervention and in Taiwan as a
whole? Is there any consensus?
Asian people traditionally don’t prefer operation because they believe
that the incidence of mortality is high, therefore the majority (>90%)
of patients with coronary artery disease in Taiwan choose intervention.
The current evidence and guidelines will not influence our approach
and we always do our best to achieve the best results through the
most delicate techniques.
From Asian data (Korea, Taiwan etc.), PCI is safe for most patients with
left main lesions, except those with a high Syntax score.
If you have a patient with left main bifurcation lesion, do you
prefer PCI or CABG?
For patients with left main bifurcation, I would prefer PCI, keeping
CABG (less than 10%) for those with complex lesions (3VD with
diffuse, coronary Chronic Total Occlusion [CTO]).
In left main PCI, do you prefer transradial or transfemoral?
Since 1998, the transradial approach of PCI has been transformed
from an alternative to the femoral into a routine method in our centre,
with enough experience and intimate knowledge of guide behaviour,
complex interventions like primary angioplasty (80%), left main
bifurcation (>90%) and CTO PCI (50%) can be safety and easily
performed via the radial route. This method achieves an excellent
procedural success rate, virtually eliminates access site complications
(bleeding) and allows rapid ambulation.
What do you think of AsiaPCR/SingLIVE and what is your vision
for the future of the Course?
AsiaPCR/SingLIVE is one of the pioneers of the PCI live demonstration
in Asia and even in the world. In the past, there were only a few
countries like Japan.
Malaysia, Korea and Taiwan joining in AsiaPCR/SingLIVE, but now with
other countries like India, Arabia and the Middle East participating,
the Course is even more fruitful. I hope we can continue to receive
different representatives of different societies and discuss, debate the
different topics together. Competition between different groups
always attracts an audience.
rendez-vous in
PARIS
15TH-18TH MAY
2012
www.europcr.com
Final Programme / 12th-14th January, 2012 / Singapore
32
Interviews
Interview with Ashwin Mehta
Guest Faculty and Interventional cardiologist at Jaslok Hospital & Research Centre in Mumbai, India
Tell us about yourself and your involvement in the cardiology
community in India.
In 1987, we preformed our first angioplasty at Jaslok Hospital &
Research Centre in Mumbai, India and now our cumulative figure
could be close to 10,000 angioplasties. I had the opportunity to
introduce high-risk angioplasty with percutaneous cardiopulmonary
support, laser myocardial revascularisation, and the intra-aortic
balloon pump, one of the first in the country. Currently, we are actively
studying fractional flow reserve in bifurcating lesions and IVUS in
coronary chronic total occlusion.
I was both President of the Cardiological Society of India in 2000 and
of the World Congress of Coronary Disease in 1981 and 1986.
Currently, I am actively involved in teaching programmes on both the
basics and complex interventional cardiology. I have been a regular
faculty member at EuroPCR and, a couple of years ago, I was assigned
a Learning The Techniques session on CTO at EuroPCR in Paris.
Do you see any increase in the number of PCI in India after the
Syntax trial or the reverse?
After the Syntax trial the number of angioplasties at my centre has
gone up and this is perhaps true for the entire country. Moderate and
low-risk Syntax cases are more confidently handled with intervention.
As the second most populated nation in the world, how accessible and affordable is PCI to the general population in India?
There is approximately 20% growth in the number of angioplasty
procedures every year in India, but we still have a long way to go.
India should be doing approximately a million procedures per year.
The limitations are the cost constraints and affordability of the procedure.
The majority of people bear the cost of their medical expenses by
themselves, but both government support and insurance-based support
are slowly increasing, making angioplasty available to patients more
easily than ever before.
Any suggestions that would improve the above?
People in India have many false impressions about angioplasty.
They believe that surgery is a permanent cure and that angioplasty is
a short lasting palliative procedure.
Once they understand the role of intervention and the positive and
negative aspects in comparison to surgery, they will be in a better
position to accept or reject angioplasty when offered.
What do you think of AsiaPCR/SingLIVE and what is your vision
for the future of the Course?
AsiaPCR/SingLIVE is an excellent venue for the promotion and growth
of knowledge in the field of intervention. It is still in its infancy, but it
is becoming more and more popular. The excellent scientific content,
beautiful hotels, excellent facilities and the closeness to India are some
of the major factors, making AsiaPCR/SingLIVE an important Course
contributing to knowledge in interventional cardiology.
Interview with Fazila Malik
Guest Faculty, Professor and Chief Consultant Cardiologist at the National Heart Foundation Hospital
& Research Institute in Dhaka, Bangladesh
What is your role or participation in the cardiology community
in Bangladesh?
As the chief consultant of a tertiary cardiac centre, I am trying to lead
the effort to perform and maintain the high quality of coronary
interventions. My aim is to introduce the latest technology in coronary
intervention in Bangladesh and to train young cardiologists in intervention and clinical cardiology.
I also participate in different international multicentre registries and
organise an annual international cardiac conference, the National
Heart Foundation Conference on Cardiovascular Disease.
What is the penetration rate of DES in your country and what
factors affect its usage?
In 2010 there were approximately 2,200 stents implanted in my centre,
of which 90% were DES. When implanting a DES we take the clinical
presentation, vessel condition and the economic status of the patient
into account.
If I have a STEMI, I would prefer bare metal stent or DES, because...
As a general offer in our centre we use BMS in primary PCI, but at the
same time, I advocate the use of DES to those who can afford it as
recent trials using DES in primary PCI have shown encouraging results.
What do you think of AsiaPCR/SingLIVE and what is your vision
for the future of the course?
Asia PCR/SingLIVE is a grand gathering of cardiologists from Asia and
all over the world.
It is the perfect platform for exchanging views and ideas and bringing
ourselves up to date not only with the latest information, but also with
the achievements of our colleagues.
I believe, as an organisation of the most populous continent,
AsiaPCR/SingLIVE will help to spread the benefits of coronary interventions among the nations.
The experience continues
@ pcronline.com
Final Programme / 12th-14th January, 2012 / Singapore
34
Singapore Night Life
Singapore: never a dull moment!
t
There is something for everyone in Singapore!
This truly cosmopolitan city is in constant movement even long
after the sun goes down, providing you with plenty of options for
putting your feet up and relaxing after a full day of learning and
sharing. Whether you want to enjoy a meal, toast with your peers,
or network after hours, Singapore has something to offer.
The Marina Bay district
t
In Singapore, the sky is the limit. Take in the jaw-dropping panorama from
the most advantageous viewpoints: overlook the Marina Bay from the
rooftop of the Esplanade while enjoying drinks and dinner at the Orgo restaurant. Appreciate the entire island city at dusk during the 32-minute rotation
on the Singapore Flyer or visit Singapore’s newest entertainment destination,
the Marina Bay Sands Hotel!
Not only is this the largest hotel in Singapore with three 55-storey towers complete with luxury shopping, dining, and world-class entertainment facilities,
but this building is also an architectural feat. Topping off the three towers is the
Sands SkyPark with an observation deck, gardens, restaurants and a swimming
pool all over 200 metres in the sky leaving a lasting impression!
t
Little India, Chinatown and Kampong Glam
- get your culture & heritage fix
Discover Singapore’s distinct neighbourhoods offering an abundance
of excellent restaurants, chic bars and amusing after-hours activities.
Do you smell spices or incense? You are most certainly in Little India!
Explore this vibrant district and experience the authenticity of its
restaurants and shops.
Head over to Chinatown and rub shoulders with the locals at the
Maxwell Road Food Centre. With over 100 stalls, you’re sure to sample
some of the best hawker food in town!
Or get caught up in the bustling and colourful Kampong Glam district.
Stray from the beaten path of Orchard Road and meander down of
Haji Lane to get the best boutique shopping experience Singapore has
to offer!
t
In the heart of the city - close to nature
Want to get some fresh air away from the bustling city?
You don’t have to go far. Head over to the Botanic Gardens located
in the centre of town and wander through the virgin rain forest until
midnight. Take in the National Orchid Garden's collection of 1,000
orchid species and 2,000 hybrids.
Prefer beaches to forests?
Get a change of scenery strolling along 7.5 km of sandy beach at
East Coast Park and take a load off at one of the many cafés or
bars. This beachside distraction won’t disappoint!
35 Final Programme / 12th-14th January, 2012 / Singapore
Find your hotel!
Wilk
ie
Rd
No
rth
Br
idg
eR
d
Vi
cto
ria
Qu
ee
n
St
St
d
ch R
Bea
2 MANDARIN ORIENTAL*****
5 Raffles Avenue, Marina Square,
039797 Singapore
4
’s R
d
Republic Blvd
Hw
y
Suntec
Tower 4
as
ah
Rd
Suntec
Tower 3
2
Ra
ffle
sb
lvd
3
5
Millenia
Tower
Marina
Promenade
Marina
Square
Marina
Leisureplex
Raffles Ave
3 PAN PACIFIC*****
7 Raffles Boulevard, Marina Square,
039595 Singapore
East Coast Pkwy
Marina
Bayfront
City
Esplanade
Mall
1 CARLTON HOTEL****
76 Bras Basah Road, 189558 Singapore
Rd
Suntec City
Nic
oll
Hw
y
Bra
sB
Esplan
ade D
r
Funan
Centre
Raffles
City
St
An
dre
w
Rd
No
rth
Bri
dg
e
Hill
St
Riv
er
Va
lle
yR
d
Rd
Raffles
Shopping
Arcade
Ni
co
ll
Be
ac
hR
d
Vi
ct
or
ia
Sta
mf
ord
The
Substation
Ro
ch
or
Shaw
Towers
St
National Museum
of Singapore
1
Ophir Rd
Singapore
Br
Art Museum
as
Ba
sa
h
Rd
5 THE RITZ-CARLTON MILLENIA SINGAPORE*****
7 Raffles Avenue, 039799 Singapore
4 CONRAD CENTENNIAL SINGAPORE*****
Two Temasek Boulevard, 038982 Singapore
The success of the 2012 edition of AsiaPCR/SingLIVE
would not be possible without you!
!
t
r
o
p
p
u
s
r
u
o
y
r
o
f
Thank you
Abbott Vascular
EMS
ACIST MEDICAL SYST
- TCTAP
Angioplasty Summit
.
Angiovention Co., Ltd
D
LT
.
CO
ASAHI INTECC
Ltd
B. Braun Singapore Pte
l Technologies Pte Ltd
na
Biosensors Interventio
Biotronik SE & Co. KG
BOSTON SCIENTIFIC
CID SpA
company
, a Johnson & Johnson
CORDIS CORPORATION
ORATION
ELIXIR MEDICAL CORP
Eurocor
CERC
lar Research Centre European Cardiovascu
HEXACATH
ces
Info Ressources Servi
D
LT
E
PT
INNOHEART
y Co., Ltd.
Japan Stent Technolog
ATION
OR
KANEKA MEDIX CORP
logy (Beijing) Co., Ltd
Lepu Medical Techno
lar
MAQUET Cardiovascu
IONAL, Ltd
AT
RN
MEDTRONIC INTE
Ltd.
t.
Meril Life Sciences Pv
MINVASYS
NTRE SINGAPORE
NATIONAL HEART CE
Pte Ltd
OrbusNeich Medical
P.G. BOOKS PTE LTD
Pie Medical Imaging
bH
Medizinprodukte Gm
Qualimed Innovative
ResearchBooks Asia
SANOFI
SIEMENS HEALTHCARE
ST JUDE MEDICAL
Ltd
TemMed Medical Co.,
N SINGAPORE BRANCH
IO
TERUMO CORPORAT
translumina GmbH
TRANSMEDIC PTE LTD
ation
ZOLL Medical Corpor
2/2011
tic order, valid as of 23/1
Classification in alphabe
Final Programme / 12th-14th January, 2012 / Singapore
36
The A-Z of AsiaPCR/SingLIVE 2012
Access
Food & beverage
Opening hours
MRT:
Esplanade Station or City Hall Interchange.
Bus:
Lines 36, 97, 106, 111, 133, 501, 502, 518, 857, 700.
Breakfast
Bento boxes will be served during Industry breakfast symposia Friday 13th outside rooms 2 and 3 at 7:45.
Tea and coffee served all day in the exhibition area.
Coffee break
Served in the exhibition area:
Thursday 12th:
8:35 and 16:15
Friday 13th:
10:00 and 16:00
Saturday 14th:
10:00
Lunch
Buffet lunch open around 12:00 in the exhibition area.
Bento boxes and meal boxes served outside the session
rooms at 12:15.
Dinner
Served during Industry dinner symposia on Thursday 12th
in front of the Main Arena and room 2 at 18:00.
Onsite registration
Wednesday 11th:
Thursday 12th:
Friday 13th:
Saturday 14th:
Scientific sessions
Thursday 12th:
Friday 13th:
Saturday 14th:
Exhibition area
Thursday 12th:
Friday 13th:
Saturday 14th:
Badge
Registration badges must be worn at all times. Access to
the exhibition area and rooms will not be permitted without
a valid and visible badge.
Bag pick-up
Located on Level 1, registration area, Suntec Main Entrance.
Case corner
Review the complications and clinical cases selected from
the “call for” on dedicated computers.
Located in the exhibition area with the cyber kiosk.
See also Interactive case corner for interactive discussions schedule.
Free
Preview room:
Wednesday 11th:
Thursday 12th:
Friday 13th:
Saturday 14th:
16:00 - 19:00
7:00 - 20:00
7:00 - 18:00
7:00 - 17:00
8:40 - 20:00
7:45 - 18:00
7:30 - 17:00
7:30 - 20:00
7:00 - 18:00
8:00 - 15:00
16:00 - 19:00
7:00 - 20:00
7:00 - 18:00
7:00 - 17:00
Your badge includes access to all scientific sessions and
the exhibition area.
PLUS lunches and coffee breaks
Photography
See "Food".
Hotels
Posters gallery
Certificate of attendance
A Carlson Wagonlit representative will be available at the
registration desk to help with your queries. See page 36 to
find the list.
Information also available on the smartphone applications.
Download it now at www.asiapcr.com!
Catering
A certificate of attendance will be delivered with your
badge at the registration desk.
Cloakroom
Located near the registration desk. Leave your luggage free
of charge. Open during registration hours.
Convention Centre
Suntec Singapore
International Convention & Exhibition Centre
1 Raffles Boulevard, Suntec City, Singapore 039593
Cyber kiosk
Located in the exhibition area. Free access to computers
connected to Internet.
Delegate lounge
A place to network with colleagues or relax located in the
exhibition area.
EuroIntervention Journal
The official journal of the European Association of Percutaneous Cardiovascular Interventions. Pick-up your free
copy at the distribution point.
Exhibitors
See the exhibition map.
Information also available with the smartphone application.
Interactive case corner
A unique concept from PCR! Come along and share with
your peers at the Interactive Case Corner, where the atmosphere is friendly, free of judgment, pressure and timelines. Case discussion is a great learning experience,
combined with well-rounded educational messages, this
will complete your educational experience at AsiaPCR/Sing
LIVE 2012.
The Interactive Case Corner is tucked away in a quiet corner of the exhibition hall.
Internet
Free WiFi is available in selected areas, follow the WiFi
signs.
If you need a computer, feel free to use the Cyber kiosk,
located in the exhibition area.
Language
English is the official language of AsiaPCR/SingLIVE.
Lost and Found
Lost property can be found at the Exhibitor Support Centre.
Located on Level 2.
Photography and filming are strictly prohibited.
Visit the poster area and participate in the moderated
discussions:
Thursday 12th
16:30 - 17:30 with Eric Eeckhout and Aaron Wong
Friday 13th
9:00 - 10:00 with Wan Ahmad Wan Azman and Philip Wong
Friday 13th
15:00 - 16:00 with Fina Mauri and Andrew Ong
Preview room
Located in room 210, for speakers & presenters only.
Please upload your slides 3 hours before your presentation.
Open starting Wednesday 11th at 16:00.
Registration
Pre-registration: if you have pre-registered, go to the
"Pre-registered" counter.
On-site registration: go to the “On-site” counter.
Session room capacity
Each session room has a limited capacity and we are unable to reserve seats, therefore once the room is full, for security reasons we will be unable to permit further access.
Smartphones
An application dedicated to the Course is available for
Android, iPhone.
Includes: breaking news, scientific programme with a
“What’s on now” option, exhibitors and more.
Download it now at www.asiapcr.com!
Smoking
Exhibitor Support Centre
The entire Convention Centre is a non-smoking area.
For exhibitors only. Information office located on Level 2
near the exhibition area.
Tourism
You will find guides to Singapore in your delegates bag.
Visits of Singapore
Visitors desk on level 1 of the Suntec City Mall, near the
entrance of the Convention Centre and the Food Republic
restaurant.
37 Final Programme / 12th-14th January, 2012 / Singapore
Plans
Interactive
Case Corner
Room 3
Room 2
Room
206
Room
205
Room
207
Room
204
Training Village
Exhibition
Hall
Exhibition
Hall
Room 208
Room 203
Room 209
Preview
Room
Main Arena
Room 201
Posters Gallery
Main Entrance
Entrance
ZONE 1
ZONE 2
DAY PASS AND FULL PASS
ACCESS ONLY
ALL TYPES OF BADGES
ZONE 1
ZONE 2
Interactive
Case Corner
Exhibition Area
Buffet
1
20 9
21
1
18 7
12 14 15 16
22 23
24 25
26
27
28
29
30
31
32
38 37
Buffet
Room 2
33
34
35
36
Room 3
1
2
6
Buffet
9
4
5
7
8
10
Lounge
40
Main Arena
Main Entrance
ZONE 1
Cyber
Cafe
1
2
4
5
6
7
8
9
10
12
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
40
BOSTON SCIENTIFIC
MAQUET Cardiovascular
ELIXIR MEDICAL CORPORATION
Meril Life Sciences Pvt. Ltd.
TERUMO CORPORATION SINGAPORE BRANCH
Abbott Vascular
HEXACATH
Biosensors Interventional Technologies Pte Ltd
Biotronik SE & Co. KG
Qualimed Innovative Medizinprodukte GmbH
translumina GmbH
TemMed Medical Co., Ltd
ZOLL Medical Corporation
P.G. BOOKS PTE LTD
Info Ressources Services
ResearchBooks Asia
Angioplasty Summit - TCTAP
Angiovention Co., Ltd.
KANEKA MEDIX CORPORATION
TRANSMEDIC PTE LTD
ST JUDE MEDICAL
European Cardiovascular Research Centre - CERC
ACIST MEDICAL SYSTEMS
SIEMENS HEALTHCARE
Japan Stent Technology Co., Ltd
ASAHI INTECC CO. LTD
B. Braun Singapore Pte Ltd
OrbusNeich Medical Pte Ltd
MINVASYS
Lepu Medical Technology (Beijing) Co., Ltd
Eurocor
Pie Medical Imaging
MEDTRONIC INTERNATIONAL, Ltd
CID SpA
INNOHEART PTE LTD
NATIONAL HEART CENTRE SINGAPORE
Final Programme / 12th-14th January, 2012 / Singapore
38